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A B S T R A C T
Background
The widespread use of mobile technologies can potentially expand the use of telemedicine approaches to facilitate communication
between healthcare providers, this might increase access to specialist advice and improve patient health outcomes.
Objectives
To assess the eFects of mobile technologies versus usual care for supporting communication and consultations between healthcare
providers on healthcare providers' performance, acceptability and satisfaction, healthcare use, patient health outcomes, acceptability and
satisfaction, costs, and technical diFiculties.
Search methods
We searched CENTRAL, MEDLINE, Embase and three other databases from 1 January 2000 to 22 July 2019. We searched clinical trials
registries, checked references of relevant systematic reviews and included studies, and contacted topic experts.
Selection criteria
Randomised trials comparing mobile technologies to support healthcare provider to healthcare provider communication and
consultations compared with usual care.
Data collection and analysis
We followed standard methodological procedures expected by Cochrane and EPOC. We used the GRADE approach to assess the certainty
of the evidence.
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Main results
We included 19 trials (5766 participants when reported), most were conducted in high-income countries. The most frequently used mobile
technology was a mobile phone, oNen accompanied by training if it was used to transfer digital images. Trials recruited participants with
diFerent conditions, and interventions varied in delivery, components, and frequency of contact. We judged most trials to have high risk
of performance bias, and approximately half had a high risk of detection, attrition, and reporting biases. Two studies reported data on
technical problems, reporting few diFiculties.
Mobile technologies used by primary care providers to consult with hospital specialists
We assessed the certainty of evidence for this group of trials as moderate to low.
Mobile technologies:
- probably make little or no diFerence to primary care providers following guidelines for people with chronic kidney disease (CKD; 1 trial,
47 general practices, 3004 participants);
- probably reduce the time between presentation and management of individuals with skin conditions, people with symptoms requiring
an ultrasound, or being referred for an appointment with a specialist aNer attending primary care (4 trials, 656 participants);
- may reduce referrals and clinic visits among people with some skin conditions, and increase the likelihood of receiving retinopathy
screening among people with diabetes, or an ultrasound in those referred with symptoms (9 trials, 4810 participants when reported);
- probably make little or no diFerence to patient-reported quality of life and health-related quality of life (2 trials, 622 participants) or to
clinician-assessed clinical recovery (2 trials, 769 participants) among individuals with skin conditions;
- may make little or no diFerence to healthcare provider (2 trials, 378 participants) or participant acceptability and satisfaction (4 trials,
972 participants) when primary care providers consult with dermatologists;
- may make little or no diFerence for total or expected costs per participant for adults with some skin conditions or CKD (6 trials, 5423
participants).
Mobile technologies used by emergency physicians to consult with hospital specialists about people attending the emergency
department
We assessed the certainty of evidence for this group of trials as moderate.
Mobile technologies:
- probably slightly reduce the consultation time between emergency physicians and hospital specialists (median diFerence −12 minutes,
95% CI −19 to −7; 1 trial, 345 participants);
- probably reduce participants’ length of stay in the emergency department by a few minutes (median diFerence −30 minutes, 95% CI −37
to −25; 1 trial, 345 participants).
We did not identify trials that reported on providers' adherence, participants’ health status and well-being, healthcare provider and
participant acceptability and satisfaction, or costs.
Mobile technologies used by community health workers or home-care workers to consult with clinic sta0
We assessed the certainty of evidence for this group of trials as moderate to low.
Mobile technologies:
- probably make little or no diFerence in the number of outpatient clinic and community nurse consultations for participants with diabetes
or older individuals treated with home enteral nutrition (2 trials, 370 participants) or hospitalisation of older individuals treated with home
enteral nutrition (1 trial, 188 participants);
- may lead to little or no diFerence in mortality among people living with HIV (RR 0.82, 95% CI 0.55 to 1.22) or diabetes (RR 0.94, 95% CI
0.28 to 3.12) (2 trials, 1152 participants);
- may make little or no diFerence to participants' disease activity or health-related quality of life in participants with rheumatoid arthritis
(1 trial, 85 participants);
- probably make little or no diFerence for participant acceptability and satisfaction for participants with diabetes and participants with
rheumatoid arthritis (2 trials, 178 participants).
Mobile technologies to support healthcare provider to healthcare provider communication and management of care (Review)










Cochrane Database of Systematic Reviews
We did not identify any trials that reported on providers' adherence, time between presentation and management, healthcare provider
acceptability and satisfaction, or costs.
Authors' conclusions
Our confidence in the eFect estimates is limited. Interventions including a mobile technology component to support healthcare provider to
healthcare provider communication and management of care may reduce the time between presentation and management of the health
condition when primary care providers or emergency physicians use them to consult with specialists, and may increase the likelihood of
receiving a clinical examination among participants with diabetes and those who required an ultrasound. They may decrease the number
of people attending primary care who are referred to secondary or tertiary care in some conditions, such as some skin conditions and CKD.
There was little evidence of eFects on participants' health status and well-being, satisfaction, or costs.
P L A I N   L A N G U A G E   S U M M A R Y
Using mobile technologies to promote communication and management of care between healthcare professionals
What is the aim of this review?
We aimed to find out if healthcare workers using mHealth services through their mobile phones or other mobile devices to communicate
with other healthcare workers provide quicker access to healthcare, and improve patient health outcomes. We collected and analysed all
relevant research and found 19 studies.
Key messages
Mobile technologies probably slightly decrease the time to deliver health care, as well as the number of face-to-face appointments, when
compared with usual care, and probably increase the number of people receiving clinical examinations for some conditions, including an
eye exam for people with diabetes. Mobile technologies may have little or no impact on healthcare workers' and participants' satisfaction,
health status or well-being.
What was studied in the review?
Many healthcare workers work alone or have little access to colleagues and specialists. This is a common problem for healthcare workers
in rural areas or low-income countries.
One possible solution to this problem is to oFer healthcare workers advice and support through mobile technologies that allow healthcare
workers to get help from colleagues who are not in the same place. For instance, healthcare workers can contact specialists or colleagues
with more experience through a phone or the Internet. Healthcare workers can also use their mobile phones or other mobile devices such
as tablets. As more healthcare workers use mobile phones and other devices as part of their work, this could make it particularly easy for
them to use mHealth services.
What are the main results of the review?
We found 19 relevant studies, which included more than 5766 people who needed health care. Sixteen studies were from high-income
countries. Two studies reported on technical problems, reporting few diFiculties.
When primary healthcare workers use mobile technologies to consult with hospital specialists, they:
- probably make little or no diFerence to whether guidelines are followed for people with chronic kidney disease, or to health status or
quality of life of people with psoriasis.
- may increase the likelihood of retinopathy screening for people with diabetes, or receiving an ultrasound if referred with symptoms, and
may reduce referrals or a visit to the clinic for people with a skin condition or referred for clinic follow-up for diFerent health problems.
- may make little or no diFerence to healthcare worker or patient satisfaction, or to how much it costs to deliver health care.
When emergency doctors use mobile technologies to consult with hospital specialists:
- patients are probably managed slightly more quickly.
We did not find any studies that looked at the eFect of mobile technologies on emergency doctors following guidelines, patients’ health
and well-being, healthcare worker or patient satisfaction, or costs.
When community health workers or home-care workers use mobile technologies to consult with clinic sta0, they:
- probably make little or no diFerence to the number of times people with a new diabetes-related foot ulcer have to see a nurse, or elderly
people using tube feeding have to see a nurse or go into hospital.
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- may make no diFerence to the number of people living with HIV or diabetes who die; and may make little or no diFerence to the health
status or quality of life of people with rheumatoid arthritis.
- probably make little or no diFerence to the satisfaction of people with diabetes or rheumatoid arthritis.
We did not find any studies that looked at the eFect of mobile technologies on whether community health workers follow guidelines, how
quickly people receive care, healthcare worker satisfaction, costs, or technical diFiculties.
How up-to-date is this review?
We searched for studies up to 22 July 2019.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Mobile technologies used by primary care providers to consult with a hospital-based specialist compared with usual care
Mobile technologies used by primary care providers to consult with a hospital-based specialist compared with usual care
Population: Primary care providers consulting with dermatologists (6 studies), ophthalmologists (2 studies), radiologists (1 study), nephrologists (1 study), or different spe-
cialists (1 study)
Setting: Primary care settings in North America (5 studies), Europe (4 studies), the Dominican Republic (1 study) or Mongolia (1 study)
Intervention: Mobile technologies for retinal screening using a non-mydriatic camera (2 studies), portable ultrasound (1 study), teledermatology to send digital images (6
studies), eConsult through audio-conferencing or secure direct messaging between healthcare providers (2 studies)
Comparison: Usual care that included a reminder to book an appointment with participant’s healthcare provider; direct booking of a face-to-face appointment; regular ex-
amination during the index face-to-face appointment with the participant’s primary care provider



















1 trial of telenephrology (Van Gelder 2017), using a web-based plat-
form with access to the electronic medical record reported OR of 1.23
(95% CI 0.89 to 1.70) for monitoring of disease and 0.61 (0.22 to 1.72)








Mobile technologies used by primary care
providers to consult with a hospital-based
specialist probably
make little or no difference to primary care
providers’ adherence to the advised monitor-
ing criteria for participants with chronic kid-










2 trials of teledermatology (Piette 2017; Whited 2002)
reported that participants allocated to IG received the required treat-
ment in less time than those allocated to CG (median delay 4 days for
IG and 40 days for CG; MD −40.5 days, 95% CI −23 to −58)
1 trial of telemedicine using a portable ultrasound (Sutherland 2009)
for people presenting with symptoms that required an ultrasound re-
ported little or no difference between groups.
1 trial of eConsult for people attending primary care (Azogil-López







The intervention probably reduces time be-
tween participants presenting and manage-
ment among individuals with some skin con-
ditions, symptoms requiring an ultrasound,
or requiring an appointment with a specialist






































































































































































































in less time than those allocated to CG (median difference −27 days,





4 trials of teledermatology (Byamba 2015; Piette 2017; Whited 2002;
Whited 2013; RRs ranged from to 0.28 (95% CI 0.13 to 0.63) to 0.82
(95% CI 0.75 to 0.88)) reported that those participants allocated to the
intervention group were less likely to be referred for clinic follow-up or
attend an appointment at a clinic
2 trials of eConsults for nephrology (Van Gelder 2017) and different
specialties (Liddy 2019a) reported little or no difference between
groups (OR 0.61, 95% CI 0.31 to 1.23 and RR 0.93, 95% CI 0.85 to 1.03,
respectively)
2 trials of telemedicine for retinopathy screening (Davis 2003; Mans-
berger 2015) and 1 trial for people presenting with symptoms that re-
quired an ultrasound (Sutherland 2009; RR 3.92, 95% CI 2.11 to 7.31)
reported that those participants allocated to the intervention group







Mobile technologies used by primary care
providers to consult with hospital-based spe-
cialists may reduce referrals and clinic visits
among people with skin conditions, and in-
crease the likelihood of receiving retinopa-
thy screening among participants with dia-
betes, and an ultrasound in those referred
with symptoms, when compared with usual
care
1 trial did not specifically report the number
of participants involved
Patient-reported quality of life and health-related quality of life (Follow-up: 9 to 12 months)
2 trials of teledermatology (Armstrong 2018; Whited 2013) found little
or no difference between groups
For health status (EQ-5D-5L): MD 0 (95% CI −0.003 to 0.003)
For quality of life (Skindex-16): IG: MD −12.0 (SD 24.5, 160 participants),
CG: MD −13.2 (SD 21.6, 164 participants)








Mobile technologies used by primary care
providers to consult with hospital-based spe-
cialists probably make little or no difference
to quality of life and health-related quality of
life among individuals with skin conditions













Mobile technologies used by primary care
providers to consult with hospital-based der-
matologists probably make little or no differ-
ence to clinical improvement among individ-
uals with skin conditions
Healthcare provider acceptability and satisfaction (follow-up immediately after the intervention)Acceptability
and satisfac-








Mobile technologies used by primary care
providers to consult with hospital-based der-






































































































































































































1 trial of teledermatology (Whited 2002) reported that GPs allocat-
ed to the intervention were more likely to agree that participants
received timely appointments and to be satisfied with the consult
process than GPs allocated to the control group
to healthcare provider acceptability and sat-
isfaction with the intervention
Participant acceptability and satisfaction (follow-up: 1 to 9 months)
4 trials of teledermatology (Eminović 2009; Piette 2017; Whited 2002;
Whited 2013) reported little or no difference between groups
1 trial reported MD 0.0 (95% CI −0.12 to 0.12; PSQ III), another trial re-
ported that 87% of participants allocated to the intervention group
were overall satisfied with treatment received, compared with 92% of
those allocated to the control group*







Mobile technologies used by primary care
providers to consult with hospital-based der-
matologists may make little or no difference
to acceptability and satisfaction of partici-




2 teledermatology trials (Eminović 2009; Whited 2013) and 1 te-
lenephrology trial (Van Gelder 2017) reported little or no difference
between groups
2 teledermatology trials (Pak 2007; Whited 2002) reported that when
loss of productivity was considered, the cost per participant was high-
er for those allocated to the intervention
1 trial of teledermatology (Byamba 2015) reported that total costs







The intervention may make little or no dif-
ference to total or expected costs per partici-




1 trial recruiting GPs consulting with dermatologists about images
they took (Pak 2007) reported that there was little or no difference be-





The intervention probably results in few or no
technical difficulties
CG: Control group; CI: Confidence interval; EQ5D: EuroQol five dimensions questionnaire; GPs: General practitioners; IG: Intervention group; MD: Median difference; OR:
Odds ratio; PSQ III: Shortened version of the Patient Satisfaction Questionnaire; RR: Risk ratio; SD: Standard deviation; SF-12: Short-Form Health Survey 12; VSQ9: Vis-
it-specific satisfaction questionnaire (VSQ9)
* Questions developed by the authors for the specific trial
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect






































































































































































































aWe downgraded one point for risk of bias due to performance and detection bias, and lack of protection against contamination.
bWe downgraded one point for risk of bias due to high risk of selection bias (2 trials), performance bias (3 trials), and reporting (2 trials) bias.
cWe downgraded one point for risk of bias due to high risk of selection (2 trials), performance (6 trials), detection (3 trials), attrition (1 trial) and reporting (2 trial) bias.
dWe downgraded one point for risk of bias due to high risk of performance (2 trials), detection (2 trials), and reporting (2 trials) bias.
eWe downgraded one point for risk of bias due to high risk of performance, attrition and reporting bias.
fWe downgraded two points for risk of bias due to high risk of selection (1 trial), performance (2 trials), detection (2 trials), and reporting (1 trial) bias.
gWe downgraded two points for risk of bias due to high risk of selection (1 trial), performance (4 trials), detection (4 trials), attrition (1 trial) and reporting (3 trials) bias.
hWe downgraded two points for risk of bias due to high risk of detection (2 trials), performance (6 trials), selection (1 trial), attrition (2 trials), contamination (1 trial) and reporting
bias (4 trials).
iWe downgraded one point for risk of bias due to high risk of performance, reporting and attrition bias.
 
 
Summary of findings 2.   Mobile technologies for use in the emergency department compared with usual care
Mobile technologies for use in the emergency department compared with usual care  
Patient or population: Emergency physicians consulting with hospital specialists about adults attending the emergency department
Setting: Turkey
Intervention: Smartphone application for secure messaging, including clinical images
Comparison: Usual care - consultation requests were done by telephone, with any clinical information sent verbally
 






Plain language statement  
Providers' adherence to recom-
mended practice, guidelines or
protocols
- - - No studies were identified  
Time between presentation and
management of the health condi-
tion
Follow-up not reported
1 trial (Gulacti 2017) reported that
those allocated with the interven-
tion group were admitted to hospital
or discharged more quickly from the
emergency department (median dif-







The intervention probably reduces time
between participants presenting and
management by a few minutes among
individuals visiting the emergency de-
partment
 
Healthcare use: length of stay in
the emergency department
Follow-up not reported
1 trial (Gulacti 2017) reported that par-
ticipant allocated to the intervention
group participants had a shorter stay
in the emergency department (median







The intervention probably slightly re-
duces length of stay among individuals







































































































































































































Participants' health status and
well-being
- - - No studies were identified  
Participant and provider accept-
ability or satisfaction
- - - No studies were identified  
Costs - - - No studies were identified  
Technical problems 1 trial (Gulacti 2017) reported that
there were no technical problems dur-






The intervention probably results in few
or no technical difficulties
 
CI: Confidence interval  
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possi-
bility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
 
Rationale for downgrading the evidence
aWe downgraded one point for risk of bias due to high risk of performance and reporting bias.
 
 
Summary of findings 3.   Mobile technologies used by community health or home-care workers compared with usual care
Mobile technologies used by community health or home-care workers compared with usual care
Patient or population: Community-based peer health workers consulting with clinic staF about receiving antiretroviral therapy, community nurses consulting with dia-
betes specialist nurses or podiatrists about adults with Type 2 diabetes, home-care nurses consulting with hospital specialists about home enteral nutrition, rural-based
physical therapists consulting with urban-based rheumatologists
Setting: Canada, Italy, Norway, Uganda
Intervention: Mobile technologies (teledermatology, mobile text messaging, interactive web-based records, video-consultations)
Comparison: Usual care - home visits or outpatient clinics


























































































































































































































- - - No studies were identified
Outpatient clinic and community nurse consultations (follow-up: 12 months)
2 trials (Iversen 2018; Orlandoni 2016) reported little or no
difference between groups for outpatient visits (MD −0.48,
95% CI −1.46 to 0.49) or community nurse consultations







Mobile technologies used by
community health or home-care workers probably
make little or no difference for outpatient clinic and
community nurse consultations of participants with
new diabetes-related foot ulcer and older individuals
treated with home enteral nutrition
Hospitalisation (Follow-up: 12 months)
Healthcare
use
1 study (Orlandoni 2016) reported that the incidence rate
ratio for hospitalisations was similar between groups
among older individuals treated with home enteral nutri-






Mobile technologies for communication between home-
visiting nursing staF consulting with a hospital physi-
cian may have little or no effect on hospitalisations
among older individuals treated with home enteral nu-
trition
Mortality among individuals living with HIV or diabetes (Follow-up: 11 to 12 months)
2 trials reported little or no differences between groups. 1
study (Chang 2011) recruited peer health workers who con-
sulted with clinic staF (RR: 0.82, 95% CI 0.55 to 1.22), and
another study (Iversen 2018) recruited community nurses
who consulted with diabetes specialist nurses (RR: 0.94,







The intervention may make little or no difference in
mortality among people living with HIV or diabetes





1 trial of rural-based physical therapists consulting with ur-
ban-based rheumatologists about adults with a clinical di-
agnosis of rheumatoid arthritis (Taylor-Gjevre 2018) report-
ed little or no difference between groups for disease activity






Mobile technologies used by community health or
home-care workers may make little or no difference for
disease activity and health-related quality of life in par-







































































































































































































CI −0.1 to 0.5; RADAI MD 0.9, 95% CI −0.5 to 2.4) or health-re-
lated quality of life (EQ5D MD −0.1, 95% CI −0.4 to 0.1)
Healthcare provider acceptability and satisfaction
- - - No studies were identified





2 trials on diabetes (Iversen 2018) and arthritis (Tay-
lor-Gjevre 2018) reported little or no difference between
groups for participants' experience with healthcare (GS-
PEQ MD 0.0, 95% CI −0.18 to 0.18) and satisfaction (VSQ9 re-







Mobile technologies used by community health or
home-care workers probably make little or no differ-
ence for participant acceptability and satisfaction for
participants with new diabetes-related foot ulcer and
participants with rheumatoid arthritis
Costs - - - No studies were identified
Technical dif-
ficulties
- - - No studies were identified
CI: Confidence interval; DAS28-CRP: Disease activity score for Rheumatoid Arthritis; EQ5D: EuroQol five dimensions questionnaire; GS-PEQ: Generic Short Patient Experi-
ences Questionnaire; MD: Mean difference; mHAQ: Modified health assessment questionnaire; RADAI: Rheumatoid arthritis disease activity index; RR: Risk ratio; VSQ9: Vis-
it-specific satisfaction questionnaire
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
Rationale for downgrading the evidence
aWe downgraded one point for risk of bias due to high risk of performance (2 studies), detection (2 studies), attrition (1 study) and reporting (1 study) bias.
bWe downgraded one point for imprecision because the 95% CI shows potential eFect on both sides of “no eFect” line and that there were few events.
cWe downgraded one point for risk of bias due to high risk of performance, detection, and attrition bias.
dWe downgraded one point for imprecision because the 95% CI shows potential eFect on both sides of “no eFect” line .
eWe downgraded one point for risk of bias due to high risk of performance (2 studies), detection (1 study), attrition (1 study) and reporting (2 studies) bias.
fWe downgraded one point for risk of bias due to high risk of performance, detection, attrition, and reporting bias.
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B A C K G R O U N D
EFective communication with other healthcare providers and
access to specialist expertise is essential for increasing health
services capacity and providing optimal care, especially in areas
where there is a shortage of healthcare providers (AAP 2015). The
widespread use of information and communication technologies
(ICT) can potentially increase the capacity of health services
by supporting communication between diFerent providers, and
providing rapid access to specialist expertise.
Description of the condition
By 2035 there will be a worldwide shortage of approximately
12.9 million skilled healthcare providers (Campbell 2013). The
biggest gaps will occur in Southeast Asia and sub-Saharan Africa,
but elsewhere too this will be a problem due to larger ageing
populations, the rising prevalence of non-communicable diseases,
migration patterns and high turnover of healthcare providers.
Remote and rural areas, where populations are likely to be poorer,
sicker and less educated, are particularly at risk (OPHI 2017; Wu
2016). Healthcare providers in those settings can be isolated and
have limited interaction with colleagues and specialists, with few
opportunities for mentoring, consultation with experts, or referrals
to other healthcare providers.
Description of the intervention
Digital technologies are increasingly used to support health
systems (WHO 2018) by providing flexible options for
communication and the exchange of information. These
technologies can be used for medical diagnostic, monitoring and
therapeutic purposes, when participants are separated by distance
or time or both, with the ultimate goal of improving the health of
individuals and communities (Steinhubi 2013). Provision of health
care at a distance is usually referred to as telemedicine (WHO 2018),
and can be implemented through mobile or fixed devices.
The exchange of information can happen synchronously (when
interactions happen in real time) or asynchronously (when there
is a lag between the clinical information being transmitted and
the response), and through diFerent channels, including video-
conferencing, mobile applications, and secure messaging (Kruse
2017; WHO 2016). The use of mobile technologies can improve
access to specialty care (Liddy 2019b), particularly for underserved
communities (Källander 2013). Widespread mobile broadband
connectivity means that even healthcare providers in remote areas
can access and communicate with their peers, improving co-
operation (Aceto 2018). The World Health Organization (WHO)
Global Observatory for eHealth conducted a survey of the WHO
Member States on the use of eHealth (WHO 2016), and reported that
of the 122 countries surveyed 70% reported on the use of mobile
health devices for consultation between healthcare professionals.
The most common areas were teleradiology, telepathology, and
teledermatology (WHO 2016), with teleradiology programmes
being widely used. Within this review our focus was on mobile
technologies to support provider-to-provider communication and
management of care.
In a bid to maximise the coverage of healthcare services and
to decrease the cost of providing health care, governments and
healthcare agencies in some countries have funded some type of
telehealth programme for provision of care, including promoting
communication and management of care between providers.
Some examples include the Technology Enabled Care Services
programme in England (NHS Commissioning Assembly 2015),
the Scottish Centre for Telehealth and Telecare (SCTT 2017), the
telehealth services provided within the Medicare programme in
the USA (MedPAC 2016), the Asia eHealth Information Network
(AeHIN 20017), the KwaZulu-Natal Experience in South Africa (Mars
2012), and the Aga Khan Development Network Digital Health
Programme, which covers remote communities in South-Central
Asia and East Africa (AKDN 2019).
How the intervention might work
The use of mobile technologies between healthcare providers
for communication, consultations and patient management might
contribute to developing professional skills and expertise, as well
as optimising multidisciplinary communication (AAP 2015) and
evidence-based clinical practice. This is particularly relevant for
settings where there is a shortage of healthcare providers, for
instance in low- and middle-income countries and in rural and
remote areas (Källander 2013). By enabling healthcare providers
who are geographically separated to exchange clinical information
and knowledge, mobile technology can facilitate universal health
coverage by increasing access to health care. In 2018 the
WHO published a classification of digital health interventions to
categorise the functionality of the diFerent applications; using this
classification as a guide we include interventions that are portable
and facilitate remote healthcare provider communication or co-
ordination of referrals, or both (WHO 2018).
Despite the possibilities, telehealth applications have been
inconsistently implemented, with varying degrees of success due to
technological challenges, legal considerations, human and cultural
factors, and uncertainty around economic benefits and cost
eFectiveness (WHO 2016), although this is changing. Overcoming
these barriers requires evidence-based implementation of
guidelines, driven both by governmental and professional medical
organisations; legislation on confidentiality, privacy and liability;
and the involvement of stakeholders in designing, implementing
and evaluating telemedicine applications, focusing on the safety
and the eFectiveness of applications (Agboola 2016).
Why it is important to do this review
The rapid progress of information and communication
technologies is accelerating the evolution of remote
communication between providers for the management of care.
This review is one of a suite of 11 Cochrane Reviews that
contributed to the WHO guideline on digital interventions for
health systems strengthening (WHO 2019), and focuses on the
eFectiveness of mobile technologies for communication and
management of care between healthcare providers who are in
diFerent locations. The eFectiveness of mobile technologies to
support patient-to-healthcare provider communication is being
assessed in another review (Gonçalves-Bradley 2018a). The
rationale for conducting this review is to assess the eFectiveness
of mobile health technologies as a method for healthcare
providers to communicate, diagnose and manage patients; and
to assess acceptability, satisfaction, resource use and technical
diFiculties. Research into the latter has been particularly neglected
(Coiera 2016), and can provide crucial information for successful
implementation.
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O B J E C T I V E S
To assess the eFects of mobile technologies versus usual care for
supporting communication and consultations between healthcare
providers on healthcare providers' performance, acceptability and
satisfaction, healthcare use, patient health outcomes, acceptability
and satisfaction, costs, and technical diFiculties.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We include randomised trials reported as full-text studies,
conference abstracts and unpublished data, irrespective of their
publication status and language of publication.
Types of participants
All types of healthcare providers (i.e. professionals, healthcare
assistants, and lay health workers) providing patient care through
mobile technologies. We included trials targeting people with
any condition, regardless of their location, setting, diagnoses, or
demographic factors such as age.
Types of interventions
We include trials comparing health care delivered through a mobile
device versus usual care. We defined 'usual care' by the setting in
which the trial took place, including face-to-face exchanges and
communication through other non-digital channels. We include
trials of healthcare providers who were geographically separated
and used information and communication technologies. We have
focused exclusively on the exchange of clinical information over
wireless and mobile technologies, mobile phones of any kind
(but not analogue land-line telephones), tablets, personal digital
assistants and smartphones, and when the healthcare provider
enquiry received a response in real-time or as immediate as
clinically appropriate. Communication channels through a mobile
device can include text messaging, video messaging, social
media, voice calls, voice-over Internet protocol (VoIP), and video-
conferencing, through soNware such as Skype, WhatsApp or Google
Hangouts.
We include:
• trials in which the healthcare provider used mobile
technologies, such as telemedicine applications, to seek clinical
guidance and support from other qualified healthcare providers
in order to deliver direct patient care. This included co-
ordination of referrals and requests for expert opinion and
diagnosis;
• trials in which the provider(s) seeking guidance was at a diFerent
location from the provider(s) oFering guidance; and
• trials in which the provider(s) seeking guidance transmitted
clinical information using a mobile device and the provider(s)
oFering guidance responded on any device, including stationary
devices.
We include trials of telemedicine interventions if they were
portable/mobile. We include trials assessing unspecified types of
communication devices for transmitting clinical information, so
long as they were mobile, since trials oNen failed to report this
detail.
We include all health issues and did not restrict the content of
clinical health information exchanged. We include trials where the
digital component of the intervention was delivered as part of a
wider package if we judged it to be the core component of the
intervention.
We excluded:
• pilot and feasibility studies (pilot study defined as "a version
of the main study that is run in miniature to test whether
the components of the main study can all work together" and
feasibility studies as "pieces of research done before a main
study"; Arain 2010);
• trials that compared diFerent technical specifications of
telecommunication technologies (e.g. diFerent communication
channels, soNware, etc.);
• trials in which the use of telecommunications technology was
not directly linked to patient care;
• trials in which the primary purpose of the intervention was
education/training;
• trials assessing the accuracy of a portable medical device.
Types of outcome measures
Main outcomes
• Providers' adherence to recommended practice, guidelines or
protocols.
• Time between presentation and management of the health
condition.
Other outcomes
• Healthcare use, including referrals, clinical examinations and
hospitalisations.
• Participants' health status and well-being, to include mortality
and measures of health status such as the Nottingham Health
Profile or the SF-36 (McDowell 2006).
• Healthcare provider acceptability and satisfaction; this includes
self-reported acceptability and satisfaction, measured with a
validated scale, such as the Physician Worklife Survey (Konrad
1999).
• Participant acceptability and satisfaction; this included self-
reported acceptability and satisfaction, measured with a
validated scale, such as the Patient Satisfaction Scale (La Monica
1986).
• Costs, including cost to the user and cost to the service (e.g.
human resources/time, training, supplies and equipment).
• Unintended consequences; these could include errors in
interpreting the data; transmission of inaccurate data, loss of
verbal and non-verbal communication cues, issues of privacy
and disclosure that might aFect interpersonal relationships,
negative impacts on equity, and technical diFiculties, for
example failure or delay in the message delivery.
Search methods for identification of studies
Electronic searches
An Information Specialist developed the search strategies in
consultation with the review authors and WHO content experts.
We used a minimum cut-oF search date of 2000, based on the
increased availability and penetration of mobile devices from that
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date onwards (ITU 2019). Appendix 1 lists the search strategies and
results.
We searched the following databases until 22 July 2019:
• Cochrane Central Register of Controlled Trials (CENTRAL; 2019,




• WHO Global Health Library.
Searching other resources
Trial registries
We searched clinicaltrials.gov (clinicaltrials.gov) and the World
Health Organization International Clinical Trials Registry Platform
(who.int/ictrp).
Grey literature
We conducted a grey literature search in August 2017, to identify
trials not indexed in the databases listed above. We searched for
relevant systematic reviews and primary studies on similar topics
using Epistemonikos (epistemonikos.org), a database of health
evidence and health-related systematic reviews. We searched the
content in mHealthEvidence (mhealthevidence.org), a database of
global literature on mHealth. We contacted authors of relevant
trials/reviews to clarify reported published information and to seek
unpublished results/data, as well as researchers with expertise
relevant to the review topic. Moreover, WHO issued a call for papers
through popular digital health communities of practice such as the
Global Digital Health Network and Implementing Best Practices,
to identify additional primary trials as well as grey literature. We
performed a backward and forward search of the primary reference
identified for each eligible trial.
Data collection and analysis
Selection of studies
We downloaded all titles and abstracts retrieved by electronic
searching to reference management databases (Distiller and
Covidence) and removed duplicates. For title and abstract
screening, we used a machine-learning classifier that is able to
assign a probability score that a given record describes or does
not describe a randomised trial (Wallace 2017). Two review authors
(from AM, BB, DGB, GV, IRC, and NH) screened titles and abstracts of
trials with at least a 10% probability of being a randomised trial, and
one review author screened those with less than a 10% probability.
We retrieved the full-text trial reports/publication of all potentially
eligible reports, and two review authors (from AM, BB, DGB, GV,
IRC, and NH) screened the full text to identify trials for inclusion
and to identify and record reasons for excluding the ineligible trials.
We resolved any disagreement through discussion, and if required
consulted a third review author (DGB or SS).
We listed trials that initially appeared to meet the inclusion criteria
but that we later excluded in the Characteristics of excluded studies
table. We collated multiple reports of the same trial so that each
trial rather than each report was the unit of interest in the review.
We also provided any information we could obtain about ongoing
studies. We recorded the selection process in suFicient detail to
complete a PRISMA flow diagram (Liberati 2009).
Data extraction and management
We used the EPOC standard data collection form and adapted it
for trial characteristics and outcome data (EPOC 2017a); we piloted
the form on five trials. One review author extracted the following
characteristics and a second review author cross-checked data
(from AM, BB, DGB, GV, IRC, and NH).
• Methods: trial design, unit of allocation, location and trial
setting, withdrawals.
• Participants: number, mean age, age range, sex, inclusion
criteria, exclusion criteria, dates conducted, other relevant
characteristics.
• Interventions: function of the intervention (monitoring,
consultation, therapy), intervention components (including
type of technology and mode of delivery, frequency of
data transmission), comparison, fidelity assessment. For this
review, we defined monitoring as the continuous evaluation
of the progress of symptoms or a condition over a period
of time; consultation as an exchange between the healthcare
provider and the participant, where the provider discusses the
participant's health status and provides guidance, support, or
information; and therapy as the ongoing management and care
of a participant, to counteract a disease or disorder.
• Outcomes: main outcomes specified and collected, time points
reported.
• Notes: funding for trial, ethical approval.
We contacted authors of included trials to seek missing data. We
noted in the Characteristics of included studies table if outcome
data were reported in an unusable way. We resolved disagreements
by consensus or by involving a third review author (DGB or SS). We
used Review Manager 5 (RevMan 5.3) for data management.
Assessment of risk of bias in included studies
One review author assessed risks of bias for each trial using the
criteria outlined in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2017), plus the guidance from the EPOC
group (EPOC 2017b), and a second review author cross-checked
data (from AM, BB, DGB, GV, IRC, and NH). We resolved any
disagreement by discussion or by involving a third review author
(DGB or SS). We assessed the risks of bias according to the following
domains.
• Random sequence generation.
• Allocation concealment.
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete outcome data.
• Selective outcome reporting.
• Baseline outcomes measurement.
• Baseline characteristics.
• Other bias.
We judged the risk of each potential source of bias as being high,
low or unclear, and provide a quotation from the trial report
together with a justification for our judgement in the 'Risk of bias'
table. We summarised the 'Risk of bias' judgements across diFerent
trials for each of the domains listed. We considered blinding
separately for diFerent key outcomes where necessary (e.g. for
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unblinded outcome assessment, risk of bias for all-cause mortality
may be very diFerent than for a participant-reported pain scale).
We assessed incomplete outcome data separately for diFerent
outcomes. Where information on risk of bias relates to unpublished
data or correspondence with a trialist, we noted this in the 'Risk of
bias' table. We did not exclude trials on the grounds of their risk of
bias but clearly reported the risk of bias when presenting the results
of the trials.
When considering treatment eFects, we took into account the risk
of bias for the trials that contributed to that outcome.
We conducted the review according to the published protocol
(Gonçalves-Bradley 2018b) and reported any deviations from it in
'DiFerences between protocol and review'.
Measures of treatment e0ect
We estimated the eFect of the intervention using risk ratios (RRs)
and associated 95% confidence intervals (CIs) for dichotomous
data. For continuous measures, we analysed the data based on
the mean, standard deviation (SD) and number of people assessed
to calculate the mean diFerence (MD) and 95% CI (Higgins 2019).
We ensured that readers could interpret an increase in scores for
continuous outcomes in the same way for each outcome, explained
the direction of eFect, and reported where the direction was
reversed if this was necessary.
Unit of analysis issues
Six trials used a cluster design (Byamba 2015; Chang 2011; Eminović
2009; Iversen 2018; Piette 2017; Van Gelder 2017). Of those trials, all
except one had controlled for unit-of-analysis errors by adjusting
for clustering, and thus were not further re-analysed.
We had planned to control for unit of analysis errors by re-analysing
the data aNer adjusting for clustering, using the intracluster
correlation coeFicient reported by the trials. When not reported, we
calculated intracluster correlation coeFicients estimates (Campbell
2000) and the formula 1+(M-1)xICC, where M is the average cluster
size (Higgins 2019). However, it was not possible to obtain average
cluster size for Byamba 2015 and as such it is possible that there are
potential unit of analysis errors associated with the eFect estimates
of that trial.
Dealing with missing data
We contacted investigators in order to verify key trial characteristics
and obtain missing outcome data where possible (e.g. when a
trial report was only available as an abstract). Whenever it was
not possible to obtain data, we reported the level of missingness
and considered how that might have impacted the certainty of the
evidence.
Assessment of heterogeneity
We conducted meta-analyses and calculated the I2 statistic to
measure heterogeneity among the trials in each analysis. We
considered an I2 value of 50% or more to represent substantial
levels of heterogeneity, but this value was interpreted in light of the
size and direction of eFects and the strength of the evidence for
heterogeneity, based on the P value from the Chi2 test (Deeks 2017).
We identified substantial heterogeneity for one of the outcomes
(mortality), but were not able to explore it by prespecified subgroup
analysis as there were not enough trials.
Assessment of reporting biases
We attempted to contact trial authors, asking them to provide
missing outcome data. Where this was not possible, and we
considered that the missing data might have introduced serious
bias, we explored the impact of including such trials in the overall
assessment of results. We were not able to explore possible
publication bias through a funnel plot (Sterne 2011), as we did not
combine a suFicient number of trials.
Data synthesis
We undertook meta-analyses for outcomes when the interventions,
participants, and underlying clinical question were similar enough
for pooling to make sense (Borenstein 2009). As there was
considerable heterogeneity, we applied a random-eFect model
(Deeks 2017). A common way that trialists indicate the presence
of skewed data is by reporting medians and interquartile ranges.
When we encountered this we noted that the data were skewed and
considered the implications.
'Summary of findings' table
Two review authors (DGB and MF) assessed the certainty of
the evidence (high, moderate, low, and very low) using the five
GRADE considerations: risk of bias, inconsistency, imprecision,
indirectness, and publication bias) (Guyatt 2008). We used methods
and recommendations described in the Cochrane Handbook
for Systematic Reviews of Interventions (Schünemann 2017) and
the EPOC worksheets (EPOC 2017c), using GRADEpro soNware
(GRADEpro GDT). We resolved disagreements on certainty ratings
by discussion and provided justification for decisions to down- or
upgrade the ratings using footnotes in the table, making comments
to aid readers' understanding of the review where necessary. We
used plain language statements to report these findings in the
review (EPOC 2017d).
We created 'Summary of findings' tables for the following outcomes
in order to draw conclusions about the certainty of the evidence
within the text of the review:
• Providers' adherence to recommended practice, guidelines or
protocols;
• Time between presentation and management of the health
condition;
• Healthcare use;
• Participants' health status and well-being;




We created three 'Summary of findings' tables, according to the
setting where the intervention was delivered (primary, secondary
and community care), as the populations in those settings, both
healthcare providers and participants, are substantially diFerent.
We considered whether there was any additional outcome
information that we were not able to incorporate into meta-
analyses, noted this in the tables and stated whether it supports
or contradicts the information from the meta-analyses. When it
was not possible to meta-analyse the data, we summarised the
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results in the text and in the 'Comments' section of the 'Summary
of findings' tables.
Subgroup analysis and investigation of heterogeneity
We categorised trials by setting (community, primary and
secondary care), according to healthcare provider type, e.g.
primary care doctors' or nurses' communication with hospital-
based specialists, or community health workers consulting with
clinic staF.
We planned to use the following outcomes in subgroup analysis.
• Time between presentation and management of the health
condition.
• Participants' health status and well-being.
We planned to use the formal statistical techniques of Mantel-
Haenszel and regression to test for subgroup interactions (Mantel
1959) but due to the limited number of studies we could not use this
technique.
Sensitivity analysis
We planned to perform sensitivity analyses defined a priori to
assess the robustness of our conclusions and explore the impact
on eFect sizes. This would have involved restricting the analysis to
published trials and to trials at low risk of bias. We did not perform
sensitivity analyses as there were no unpublished trials and within
the pooled analyses all the trials had the same risk of bias for the
relevant 'Risk of bias' criteria.
R E S U L T S
Description of studies
We identified 19 published randomised trials of mobile
technologies to support healthcare provider to healthcare provider
communication and management of care (see Characteristics of
included studies).
Results of the search
We retrieved 20,949 records for title and abstract screening,
screened the full-text of 2041 citations and included 19 trials
(35 citations) (Armstrong 2018; Azogil-López 2019; Byamba 2015;
Chang 2011; Davis 2003; Eminović 2009; Gulacti 2017; Iversen
2018; Liddy 2019a; Mansberger 2015; Orlandoni 2016; Pak 2007;
Piette 2017; Riordan 2015; Sutherland 2009; Taylor-Gjevre 2018; Van
Gelder 2017; Whited 2002; Whited 2013). In addition, we identified
15 ongoing trials (ACTRN12617000389303; ACTRN12618001007224;
Gervès-Pinquié 2017; Jeandidier 2018; Källander 2015; Koch 2018;
Nakayama 2016; Stevanovic 2017; NCT02821143; NCT02986256;
NCT03137511; Done 2018; NCT03559712; NCT03662256; Xu 2017).
A total of 441 records were eligible for the associated review on
mobile technologies to support patient to healthcare provider
communication and management of care (Gonçalves-Bradley
2018a). Figure 1 presents the results of the search.
 
Mobile technologies to support healthcare provider to healthcare provider communication and management of care (Review)










Cochrane Database of Systematic Reviews




Seventeen trials included 5766 participants, while two trials did
not report the specific number of participants (Liddy 2019a;
Riordan 2015). The number of healthcare professionals recruited
ranged from one general practitioner (GP) consulting with one
ophthalmologist (Davis 2003), to another trial that randomised
113 GPs consulting with several specialty physicians (Liddy
2019a). Most of the trials involved primary care professionals
consulting with specialists, namely dermatologists (Armstrong
2018; Byamba 2015; Eminović 2009; Pak 2007; Piette 2017; Whited
2002; Whited 2013), ophthalmologists (Davis 2003; Mansberger
2015), nephrologists (Van Gelder 2017) or radiologists (Sutherland
2009). In two studies more than one type of specialist was involved
(Azogil-López 2019; Liddy 2019a). The GPs mainly worked in urban
settings and consulted with specialists also located in urban
settings (N = 11). In four studies the GPs were located in rural
settings, and consulted with providers in urban settings. There
was one trial each for community-based peer health workers
consulting with clinic staF (Chang 2011), home-visiting nursing staF
consulting with a hospital physician (Orlandoni 2016), rural-based
physical therapists consulting with rheumatologists (Taylor-Gjevre
2018), and community nurses consulting with specialist nurses
or podiatrists (Iversen 2018). Two trials reported on emergency
physicians consulting with hospital-based specialists (Gulacti 2017;
Riordan 2015).
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All trials recruited adults, with Sutherland 2009 also recruiting
adolescents and Azogil-López 2019 recruiting participants aged
seven years and older, and Orlandoni 2016 specifically recruiting
participants aged 65 years and older. Three trials recruited
participants with diabetes (Davis 2003; Mansberger 2015; Iversen
2018), and one with rheumatoid arthritis (Taylor-Gjevre 2018).
Seven trials recruited participants with a range of conditions
seeking referral to a dermatologist (Armstrong 2018; Byamba
2015; Eminović 2009; Pak 2007; Piette 2017; Whited 2002; Whited
2013), two trials recruited participants attending the emergency
department (Gulacti 2017; Riordan 2015) or requiring a hospital
referral (Azogil-López 2019; Liddy 2019a), and one trial each
recruited participants requiring a trans-abdominal or trans-vaginal
ultrasound (Sutherland 2009) or with chronic kidney disease (Van
Gelder 2017). The two remaining trials recruited participants
receiving antiretroviral therapy (Chang 2011) and home enteral
nutrition (Orlandoni 2016).
Setting
Trials were mainly conducted in North America (9 trials) and
Europe (six trials), with one trial each conducted in the Dominican
Republic, Turkey, and Uganda, and Mongolia.
Interventions
The trials included in the review evaluated interventions that
varied in mode of delivery, number of sessions, and healthcare
providers involved. All trials used a portable device, 10 of them
using a portable device to obtain clinical images which were then
transmitted for further assessment (Armstrong 2018; Byamba 2015;
Davis 2003; Eminović 2009; Mansberger 2015; Pak 2007; Piette
2017; Sutherland 2009; Whited 2002; Whited 2013). Four trials
used mobile phones for text messages and voice calls (Chang
2011), secure messaging (Gulacti 2017), audio-conferencing system
(Azogil-López 2019), and for interactive web-based record and voice
calls (Iversen 2018). Two trials used a tablet for secure messaging
(Riordan 2015) or video consultation (Orlandoni 2016), whereas
one trial employed a laptop for video consultation (Taylor-Gjevre
2018). The remaining trials used an electronic health record system
for eConsults, which could also be implemented through mobile
phones (Liddy 2019a; Van Gelder 2017).
The trials also varied in the frequency and duration of contacts
between the healthcare providers, with most trials consisting of a
single consultation (e.g. Eminović 2009).
Although the control group was always described as receiving
usual care, the description of the specific care received varied. For
trials conducted in primary care, 'usual care' generally consisted
of a referral for a face-to-face appointment in secondary care
(Byamba 2015; Eminović 2009; Liddy 2019a; Pak 2007; Whited 2002;
Whited 2013) or a reminder to book an appointment (Davis 2003;
Mansberger 2015; Piette 2017; Sutherland 2009). For one trial that
used a social media platform for emergency department physicians
to communicate with specialists within the same hospital (Gulacti
2017), 'usual care' was to consult by phone, sending all clinical
information verbally. For trials conducted in the community, 'usual
care' was typically face-to-face appointments with specialists,
either at the participant's home (Orlandoni 2016) or at outpatient
clinics (Iversen 2018; Taylor-Gjevre 2018).
Several trials reported on additional components of the
intervention (Table 1). Nine reported the delivery of training
(Armstrong 2018; Byamba 2015; Chang 2011; Eminović 2009;
Iversen 2018; Mansberger 2015; Piette 2017; Sutherland 2009;
Taylor-Gjevre 2018), which usually focused on how to acquire
digital images or use the web-based system. For one trial of
eConsult, the specialists received financial incentives for each
eConsult they undertook (Liddy 2019a), and two trials provided
monetary incentives for participants to take part (Armstrong 2018)
or to complete follow-up assessment (Mansberger 2015). Two
trials reported that participants whose healthcare providers were
allocated to the intervention group had increased access to health
care, either directly (Armstrong 2018) or indirectly (Chang 2011).
Funding, ethical approval, and conflict of interest
Sixteen trials reported funding sources, all of which were provided
by medical research institutes or university funding bodies. One of
the trials also received funding from a biopharmaceutical company
(Van Gelder 2017). Three trials did not report ethical or institutional
review board approval (Byamba 2015, letter; Davis 2003, short
report; Riordan 2015, conference abstract).
For three trials one or more members of the author team reported
financial support from pharmaceutical companies (Armstrong
2018, 3/29 authors; Van Gelder 2017 1/10 authors; Whited 2013,
1/18 authors). The lead author of Pak 2007 was the co-founder
of a web-based consultation service identical to that used in the
intervention. Six studies did not report conflicts of interest (Chang
2011; Davis 2003; Riordan 2015; Sutherland 2009; Taylor-Gjevre
2018; Whited 2002), and for the remaining nine studies the authors
had no known conflict of interest.
Excluded studies
We excluded 1544 full texts, of which we report on 22 excluded trials
(See Characteristics of excluded studies). The most frequent reason
for excluding trials was the explicit use of non-mobile equipment
(eight trials).
Risk of bias in included studies
Figure 2 presents a graph for risk of bias and Figure 3 summarises
risk of bias.
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Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Baseline outcome measurements similar (selection bias)
Baseline characteristics similar (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of objective outcome assessment (detection bias)
Blinding of subjective outcome assessment (detection bias)
Protection against contamination
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
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Armstrong 2018 + + + + - + - - + - +
Azogil-López 2019 + + ? - - + + - + +
Byamba 2015 + + ? ? ? ? + + + +
Chang 2011 ? + + + - ? + - - +
Davis 2003 ? ? ? ? ? ? ? ? ? ? ?
Eminovi# 2009 + + + + - ? - ? - - ?
Gulacti 2017 + ? ? + - + ? + - +
Iversen 2018 + + ? ? - + - ? + - +
Liddy 2019a + + + + - + ? - + +
Mansberger 2015 + + ? + - - ? + ? -
Orlandoni 2016 + + + + - - ? - + +
Pak 2007 + + ? - - + + ? - - +
Piette 2017 + + ? - - - - + + + +
Riordan 2015 ? ? ? ? ? ? ? ? ? ? ?
Sutherland 2009 - - ? ? - + + + + +
Taylor-Gjevre 2018 + + + + - - - ? - - +
Van Gelder 2017 + + ? + - - - - + + +
Whited 2002 ? + + ? - + - ? + - +
Whited 2013 + + + + - - - ? - - +
 
Allocation
Fourteen trials described the generation of the randomisation
schedule, and were judged at low risk of bias (Armstrong 2018;
Azogil-López 2019; Byamba 2015; Eminović 2009; Gulacti 2017;
Iversen 2018; Liddy 2019a; Mansberger 2015; Orlandoni 2016; Pak
2007; Piette 2017; Taylor-Gjevre 2018; Van Gelder 2017; Whited
2013), one trial that 'tossed a coin' was judged as high risk of bias
(Sutherland 2009), and we rated the remaining trials at unclear risk
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of bias. FiNeen trials were judged at low risk of bias for allocation
concealment (Armstrong 2018; Azogil-López 2019; Byamba 2015;
Chang 2011; Eminović 2009; Iversen 2018; Liddy 2019a; Mansberger
2015; Orlandoni 2016; Pak 2007; Piette 2017; Taylor-Gjevre 2018;
Van Gelder 2017; Whited 2002; Whited 2013), one at high risk
(Sutherland 2009), and the remaining trials were unclear due to a
lack of information.
Eight trials reported baseline outcome measurements that were
similar between groups, thus being assessed at low risk of
bias (Armstrong 2018; Chang 2011; Eminović 2009; Liddy 2019a;
Orlandoni 2016; Taylor-Gjevre 2018; Whited 2002; Whited 2013),
and the remaining 11 trials were assessed as being at unclear risk
of bias. Ten trials reported similar baseline characteristics between
groups and we judged them to be at low risk of bias (Armstrong
2018; Chang 2011; Eminović 2009; Gulacti 2017; Liddy 2019a;
Mansberger 2015; Orlandoni 2016;Taylor-Gjevre 2018; Van Gelder
2017; Whited 2013), three trials reported diFerences between
groups at baseline and we judged them to be at high risk of bias
(Azogil-López 2019; Pak 2007; Piette 2017), and the remaining six
trials were unclear.
Blinding
Due to the nature of the intervention it was oNen not possible to
blind participants or healthcare professionals. We judged 16 trials
to be at high risk of performance bias, and three at unclear (Byamba
2015; Davis 2003; Riordan 2015).
For objective outcomes we assessed six trials to be at high risk
of detection bias (Mansberger 2015; Orlandoni 2016; Piette 2017;
Taylor-Gjevre 2018; Van Gelder 2017; Whited 2013), eight trials to
be at low risk of bias and five trials to have an unclear risk of bias
(Byamba 2015; Chang 2011; Davis 2003; Eminović 2009; Riordan
2015). For subjective outcomes we assessed eight trials to be at
high risk of detection bias (Armstrong 2018; Eminović 2009; Iversen
2018; Piette 2017; Taylor-Gjevre 2018; Van Gelder 2017; Whited
2002; Whited 2013), one trial to be at low risk of bias (Pak 2007), and
two trials to have an unclear risk of bias (Davis 2003; Riordan 2015).
Eight trials did not collect data on subjective outcomes.
Incomplete outcome data
Eight trials had high rates of incomplete outcome data and we
judged them to be at high risk of attrition bias (Azogil-López 2019;
Chang 2011; Eminović 2009; Liddy 2019a; Orlandoni 2016; Pak 2007;
Taylor-Gjevre 2018; Whited 2013), and nine trials at low risk of
attrition bias and were unclear about two trials (Davis 2003; Riordan
2015).
Selective reporting
We judged nine trials to be at high risk of reporting bias, as
either outcomes were not reported per protocol (Armstrong 2018;
Eminović 2009; Gulacti 2017; Iversen 2018; Taylor-Gjevre 2018;
Whited 2013) or publications were found for the same trial without
cross-reference (Chang 2011; Pak 2007; Whited 2002). For three
trials it was not possible to make a judgement due to a lack
of information (Davis 2003; Mansberger 2015; Riordan 2015), and
seven trials had a low risk of reporting bias.
Other potential sources of bias
We judged other potential sources bias as unclear in three trials,
two because there was not enough information (Davis 2003;
Riordan 2015), and the other due to several methods being reported
to collect outcome data due to problems with follow-up (Eminović
2009). We judged one trial to have a high risk of other potential
sources of bias, as data collection methods diFered for the two trial
groups and were not clearly reported (Mansberger 2015). There was
no other apparent source of bias for the remaining trials and we
judged them to be at a low risk of bias.
E0ects of interventions
See: Summary of findings 1 Mobile technologies used by primary
care providers to consult with a hospital-based specialist compared
with usual care; Summary of findings 2 Mobile technologies
for use in the emergency department compared with usual care;
Summary of findings 3 Mobile technologies used by community
health or home-care workers compared with usual care
Comparison 1: Mobile technologies used by primary care
providers to consult with hospital based specialists
Thirteen trials reported on mobile technologies used by primary
care providers to consult with hospital-based specialists. The
studies involved GPs consulting with dermatologists (Armstrong
2018; Byamba 2015; Eminović 2009; Pak 2007; Piette 2017; Whited
2002; Whited 2013), ophthalmologists (Davis 2003; Mansberger
2015), radiologists (Sutherland 2009), nephrologists (Van Gelder
2017), or diFerent specialists (Azogil-López 2019; Liddy 2019a).
The mobile component of the interventions consisted of a non-
mydriatic camera for retinal screening (Davis 2003; Mansberger
2015), portable ultrasound (Sutherland 2009), teledermatology to
send digital images (Armstrong 2018; Byamba 2015; Eminović 2009;
Pak 2007; Piette 2017; Whited 2002; Whited 2013), and eConsult
through audio-conferencing or secure direct messaging between
healthcare providers, with a mobile component (Azogil-López 2019;
Liddy 2019a; Van Gelder 2017). For an overview of the evidence
please refer to Summary of findings 1.
Main outcomes
1. Providers' adherence to recommended practice, guidelines or
protocols
One trial reported on the use of telenephrology by nephrologists
to communicate with primary care providers for people with
chronic kidney disease (CKD) (Van Gelder 2017). The authors found
little or no diFerence for providers' adherence to the advised
monitoring criteria from national CKD guidelines, as measured by
monitoring of disease progression and metabolic parameters (3004
participants; moderate-certainty evidence; Analysis 1.1). Follow-up
was not reported.
2. Time between presentation and management of the health
condition
Four trials reported on time between presentation and
management of the health condition (656 participants; moderate-
certainty evidence; Analysis 2.1). Two trials recruited GPs who
collected digital images from people with a skin condition and
consulted with hospital-based dermatologists on how to interpret
them, reporting that people received the required treatment
from their dermatologist in less time than those allocated to
the control group: for Whited 2002 mean diFerence −40.5 days,
95% CI −23 to −58 days (275 participants); Piette 2017 reported
a median of 4 days for the intervention group (IG) and 40 days
for the control group (CG), with an adjusted hazard ratio (HR) of
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2.55, P = 0.01 (103 participants). A third trial recruited GPs who
shared ultrasound images with radiologists, finding little or no
diFerence between groups on median time to participant follow-up
or diagnosis (Sutherland 2009; 105 participants). Azogil-López 2019
recruited GPs who either referred their participants to an in-person
hospital appointment (control group) or to an audio-consultation
(intervention group), finding that those allocated to the audio-
consultation waited for less time (median −27 days, 99% CI −20
to −33 days; 173 participants). Follow-up, when provided, ranged
between three and six months.
Other outcomes
1. Healthcare use
Nine trials reported on various forms of healthcare use,
including referrals, screening examinations, outpatient visits and
hospitalisations (4810 participants; moderate-certainty evidence;
Analysis 3.1).
Four trials recruited GPs who consulted with dermatologists
through the use of digital images (Byamba 2015; Piette 2017;
Whited 2002; Whited 2013; 4 trials, 1075 participants; follow-up
between three and nine months, when reported), finding that
those participants allocated to the intervention group were less
likely to subsequently receive a referral for an appointment with a
dermatologist, visit a dermatology clinic, or be referred to tertiary
care: risk ratio (RR) ranged from 0.28 (95% CI 0.21 to 0.38) to 0.82
(0.75 to 0.88). We did not retain the meta-analysis because of high
statistical heterogeneity (Analysis 3.2; I2 = 91%).
One trial of eConsults between PCPs and nephrologists reported
that there was little or no diFerence between groups for referral rate
(odds ratio (OR) 0.61, 95% CI 0.31 to 1.23; Van Gelder 2017; 3004
participants). Another trial of eConsults between PCPs and a range
of specialists also found little or no diFerence between groups for
face-to-face referral (RR 0.93, 95% CI 0.85 to 1.03; Liddy 2019a).
Two trials of retinopathy screening for participants with diabetes
(Davis 2003; Mansberger 2015) reported that those allocated to
the intervention group were more likely to receive a screening
examination (2 trials, 626 participants; 12 months follow-up
when reported). High statistical heterogeneity precluded retaining
the meta-analysis (Analysis 3.3; I2 = 85%). Another trial of GPs
consulting with radiologists about participants requiring a trans-
abdominal or trans-vaginal ultrasound found that participants
allocated to the intervention group were more likely to receive
an ultrasound (RR 3.92, 95% CI 2.11 to 7.31; Sutherland 2009; 105
participants).
2. Participants' health status and well-being
Two trials reported on a dermatologist providing feedback to GPs
based on digital images, finding similar scores between those
allocated to the intervention and the control group, for general
health status at 12-month follow-up (Armstrong 2018), as well as
quality of life and health-related quality of life as reported by
the participants, at nine-month follow-up (Whited 2013) (2 trials,
622 participants; moderate-certainty evidence; Analysis 4.1). Two
teledermatology trials reported on clinical course as assessed
by dermatologists at four- (Pak 2007) and nine-month follow-
up (Whited 2013), finding little or no diFerence between groups
in clinical course (2 trials, 769 participants; moderate-certainty
evidence; Analysis 4.2).
3. Healthcare provider acceptability and satisfaction
Two trials (378 participants) recruited GPs who consulted with
dermatologists using digital images (low-certainty evidence);
Piette 2017 reported little or no diFerence between groups for
acceptability or satisfaction, and Whited 2002 reported that GPs
allocated to the intervention were more likely to agree that
participants received timely appointments and to be satisfied
with the consult process than GPs allocated to the control group.
One additional trial (Van Gelder 2017) reported on satisfaction
for healthcare professionals allocated to the intervention group
(Analysis 5.1).
4. Participant acceptability and satisfaction
Four trials (972 participants, low-certainty evidence; Analysis 5.2)
recruiting GPs who consulted with dermatologists through the use
of digital images reported little or no diFerence in participant
satisfaction between those allocated to the intervention or to care
as usual (Eminović 2009; Piette 2017; Whited 2002; Whited 2013).
5. Costs
Six trials reported costs (5423 participants; low-certainty evidence;
Analysis 6.1). One teledermatology trial reported that the expected
cost per participant per visit was higher for the intervention group
(Whited 2002; 275 participants); a second teledermatology trial
reported that the total direct costs were lower for the comparison
group (Pak 2007; 698 participants; MD USD −4678, 95% CI −4720 to
−4635), and that this diFerence was oFset by the lost productivity
for participants allocated to the control group (MD USD 14,409, 95%
CI 14,398 to 14,419). Another teledermatology trial reported little or
no diFerence between groups for total costs per participant from
the healthcare perspective (MD USD 30, 95% CI USD −79 to 20),
and from the societal perspective that included the cost of loss
of productivity (MD USD −82, 95% CI −12 to −152) per participant
allocated to the intervention (Whited 2013; 391 participants). Two
trials (teledermatology and telenephrology, respectively) reported
little or no diFerence between groups for costs (Eminović 2009, 605
participants; MD EUR 32.5, 95% CI −29.0 to 74.7; Van Gelder 2017;
3004 participants; IG: EUR 453.86, 95% CI 392.98 to 514.74; CG EUR
433.74, 95% CI 387.64 to 479.84, P = 0.60). One teledermatology
trial set in rural areas in Mongolia reported lower costs associated
with the intervention group, mainly explained by the long distances
that those allocated to the control group had to travel, which was
avoided with teledermatology (Byamba 2015; 450 participants, IG:
USD 320, CG: 3174, diFerence USD 2854).
6. Unintended consequences
Four trials reported on the quality of the data transmitted
(Analysis 7.1). However, only one trial recruiting GPs consulting
with dermatologists about images they took from their participants
reported data for both groups (Pak 2007), reporting that 10 images
from each group were lost due to technical problems (1 trial, 698
participants; moderate-certainty evidence). The remaining trials
reported results for the intervention group only (Piette 2017,
Sutherland 2009, Whited 2002).
One trial where GPs could consult with dermatologists about
people with psoriasis collected data about mortality as part of
adverse events, reporting one death for each group (IG: 1/148; CG:
1/148; Armstrong 2018).
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Comparison 2: Mobile technologies for communication
between specialists in the emergency department
Two trials reported on mobile technologies for communication
between physicians and specialists in the emergency department
(Gulacti 2017; Riordan 2015), using a smartphone application for
secure messaging. For an overview of the evidence please refer to
Summary of findings 2.
Main outcomes
1. Providers' adherence to recommended practice, guidelines or
protocols
Neither of the trials of mobile technologies for communication
between specialists in the emergency department reported data on
providers' adherence.
2. Time between presentation and management of the health
condition
One trial that recruited emergency physicians who consulted with
specialist physicians using a smartphone application reported that
participants allocated to the intervention group were probably
either admitted to hospital or discharged in slightly less time from
the emergency department (median diFerence −12 minutes, 95% CI




One trial reported that participants seen by emergency physicians
allocated to the intervention group probably had a shorter length
of emergency department stay (median diFerence −30 minutes,
95% CI −37 to −25 minutes; 345 participants; moderate-certainty
evidence; Analysis 9.1, Gulacti 2017).
2. Participants' health status and well-being
Neither of the trials of mobile technologies for communication
between specialists in the emergency department reported data on
participants' health status and well-being.
3. Healthcare provider acceptability and satisfaction
Neither of the trials on mobile technologies for communication
between specialists in the emergency department reported data on
healthcare provider acceptability or satisfaction.
4. Participant acceptability and satisfaction
Neither of the trials on mobile technologies for communication
between specialists in the emergency department reported on
participant acceptability and satisfaction.
5. Costs
Neither of the trials on mobile technologies for communication
between specialists in the emergency department reported data on
costs.
6. Unintended consequences
Gulacti 2017 reported that there were no technical problems during
the course of the trial (Analysis 10.1).
Comparison 3: Mobile technologies used by community health
or home-care workers
Four trials reported on mobile technologies used by community-
based health workers or home-care workers. The professionals
involved were community-based peer health workers consulting
with clinic staF about receiving antiretroviral therapy (Chang
2011); community nurses consulting with diabetes specialist
nurses or podiatrists about adults with Type 2 diabetes (Iversen
2018); home-care nurses consulting with hospital specialists about
home enteral nutrition (Orlandoni 2016); and rural-based physical
therapists consulting with urban-based rheumatologists (Taylor-
Gjevre 2018). The mobile-based component of the interventions
consisted of mobile phone, teledermatology, video-consultations,
and interactive web-based records, respectively. For an overview of
the evidence please refer to Summary of findings 3.
Main outcomes
1. Providers' adherence to recommended practice, guidelines or
protocols
None of the trials of mobile technologies used by community-based
health workers reported data on providers' adherence.
2. Time between presentation and management of the health
condition
None of the trials of mobile technologies used by community
health workers reported data on time between presentation and
management of the health condition.
Other outcomes
1. Healthcare use
Two studies reported on outpatient clinic and community nurse
consultations (370 participants, moderate-certainty evidence).
Iversen 2018 recruited community nurses consulting with diabetes
specialist nurses and podiatrists about adults with new diabetes-
related foot ulcers, reporting little or no diFerence between
groups for outpatient consultations (0.48 fewer consultations in
the intervention group, 95% CI −1.46 to 0.49) or community nurse
consultations (0.92 more consultations in the intervention group,
95% CI −0.70 to 2.53). One trial (188 participants) that recruited
home-visiting staF who consulted with hospital physicians through
video-conferencing about older adults treated with home enteral
nutrition reported little or no diFerence for healthcare use, as
measured by outpatient visits (Incidence rate ratio 95% CI 0.65 to
1.30, P = 0.62) and hospitalisations (Incidence rate ratio 95% CI 0.54
to 1.19, P = 0.26) (Orlandoni 2016; low-certainty evidence; Analysis
11.1).
2. Participants' health status and well-being
Two trials, one recruiting community-based peer health workers
consulting with clinic staF about adults who were receiving or
started receiving antiretroviral therapy (Chang 2011) and another
recruiting community nurses consulting with diabetes specialist
nurses and podiatrists about adults with new diabetes-related foot
ulcers (Iversen 2018), reported mortality at 11- to 12-month follow-
up (RR 0.82, 95% CI 0.55 to 1.22 and RR 0.94, 95% CI 0.28 to 3.12,
respectively; 1157 participants; low-certainty evidence; Analysis
12.1).
One trial (85 participants) of rural-based physical therapists
consulting with urban-based rheumatologists about adults with
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a clinical diagnosis of rheumatoid arthritis reported little or
no diFerence between groups for health-related quality of life
and disease activity (low-certainty evidence) (Taylor-Gjevre 2018;
Analysis 12.1).
3. Healthcare provider acceptability and satisfaction
None of the trials of mobile technologies used by community
health workers reported data on healthcare provider acceptability
or satisfaction.
4. Participant acceptability and satisfaction
Two trials (178 participants) reported on participants' experience
with healthcare (Iversen 2018) and satisfaction with the
intervention (Taylor-Gjevre 2018), reporting little or no diFerence
between those allocated to the intervention or the control groups
(moderate-certainty evidence) (Analysis 13.1).
5. Costs
One trial reported the total cost of running the intervention and
cost per participant for the intervention group only (Chang 2011,
Analysis 14.1).
6. Unintended consequences
A trial that recruited community-based peer health workers
consulting with clinic staF about adults who were receiving or
started receiving antiretroviral therapy reported that healthcare
professionals allocated to the intervention were not always able
to charge the mobile phone, and that some mobile phones
were stolen (Chang 2011; Analysis 15.1). Another trial where
community nurses consulted with diabetes specialist nurses and
podiatrists about adults with new diabetes-related foot ulcers
through videoconference, reported that images were not always
transmitted (Taylor-Gjevre 2018).
Equity considerations
Some of the included trials were designed and implemented to
address geographical (Byamba 2015; Chang 2011; Davis 2003;
Taylor-Gjevre 2018) or socio-economic limitations (Mansberger
2015; Sutherland 2009) on access to health care, and thus
to promote equity for rural-based and other disadvantaged
populations who would have less access to health care (Table 2).
Even when a trial was specifically designed to address inequities
identified a priori, it might still exclude the most vulnerable
elements of the targeted population. Chang 2011 recruited peer
health workers in rural Uganda, giving them access to experienced
clinical staF through text messages and mobile phone calls, in order
to provide better health care to HIV-positive people. The peer health
workers could interact with the participants using the mobile
phone. The authors concluded that the relatively low penetration
of mobile phones in Uganda, which at the time was 39%, alongside
the challenges posed with phone-charging in a setting where access
to electricity is limited, might not only have limited the benefits
of the intervention but also increased inequities. Furthermore, the
authors also noted that the costs of the intervention could have
been a limiting factor for the peer health workers, as the monthly
stipend given for mobile phone credits was not always enough.
Whited 2013 excluded people who could not speak or read English,
as well as those who failed a single-question literacy assessment.
Gulacti 2017 assessed the use of a messaging system for
communication between emergency physicians in the emergency
department and physicians working elsewhere in the hospital,
excluding consultants who did not own a smartphone with a secure
messaging service.
Armstrong 2018 excluded people without access to the Internet and
either a digital camera or a mobile phone with camera features.
D I S C U S S I O N
Summary of main results
We included 19 randomised trials of mobile technologies that
recruited more than 5766 participants with varied conditions
and health problems. Healthcare professionals included general
practitioners, community-based peer health workers, nurses
and physiotherapists, who consulted with specialist healthcare
professionals in another healthcare facility, and emergency
physicians who consulted colleagues within the same facility.
Most trials reported on the use of mobile technologies by
general practitioners to consult with specialists, and reported that
mobile technologies reduced the time between presentation and
management of the health problem (4 trials, 656 participants;
moderate-certainty evidence). Accessing healthcare services
through mobile technologies may reduce referrals and clinic
visits among people with skin conditions and those with chronic
kidney disease, and increase the likelihood of receiving an eye
examination among people with diabetes and people referred for
an ultrasound (9 trials, 4810 participants when reported, moderate-
certainty evidence). There was little evidence of a diFerence to
patient-reported quality of life outcomes (2 trials, 622 participants),
clinician-reported outcomes of disease progression (2 trials,
769 participants); or to healthcare providers and participants'
satisfaction and acceptability, or cost (6 trials, 5423 participants,
low-certainty evidence). One trial reported on images being lost
during transmission, when using mobile technologies and also in
usual care; and one trial reported a few experiences of mobile
phones not being charged or being lost. However, most trials did
not measure or report technical problems.
Four studies reported on the use of mobile technologies by
community health or home-care workers to consult with clinic staF,
there was little evidence of an eFect on consultations in the trials
that recruited participants with new diabetes-related foot ulcer
or older individuals treated with home enteral nutrition (2 trials,
370 participants; moderate-certainty evidence). There was little or
no diFerence for hospitalisations among older individuals treated
with home enteral nutrition (1 trial, 188 participants; low-certainty
evidence), or mortality among people living with HIV or diabetes
(2 trials, 1157 participants), for disease activity and health-related
quality of life in participants with rheumatoid arthritis (1 trial, 85
participants) or participant acceptability and satisfaction in people
with new diabetes-related foot ulcer or rheumatoid arthritis (178
participants).
Overall completeness and applicability of evidence
Most trials did not report data on providers' adherence, five
trials reported on time between presentation and management
of the health condition for the main comparison, and for the
remaining comparisons and outcomes we identified very little
evidence. A third of the trials recruited adults seeking care
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for dermatological conditions, reflecting current use of mobile
technologies in healthcare settings.
The use of mobile technologies for communication between
healthcare professionals and patient management might be
particularly relevant for settings where there is a shortage of
healthcare providers. However, most of the trials were conducted in
high-income (eleven trials in North America and six trials in Europe)
or upper-middle-income countries (two trials, one in North America
and one in Asia), with one trial each conducted in a lower-middle
rural country (Mongolia) and a low-income country (Uganda). A
similar range of countries was reported in a review of mobile
technologies for healthcare service delivery processes (Free 2013).
Specific challenges might arise when implementing trials in those
contexts, such as the lack of access to power sockets to charge the
mobile phones, highlighted by the peer health workers interviewed
by Chang 2011 in Uganda but not in the study conducted in
Mongolia.
Similar contextual factors might contribute to the applicability
of the evidence. One factor oNen mentioned was the variation
in healthcare professionals' willingness to use mHealth (Azogil-
López 2019; Liddy 2019a), to attend training (Liddy 2019a), to
invite people to participate (Eminović 2009), to select participants
for electronic referrals (Van Gelder 2017), or to hold face-to-face
appointments (Iversen 2018), or provide the required feedback
(Sutherland 2009). Four trials reported that recruited participants
might not have been representative of the general population, as
the study population was more educated (Armstrong 2018), more
likely to be male (Mansberger 2015; Whited 2002; Whited 2013),
and more likely to be healthier (Armstrong 2018; Mansberger 2015).
There was also variation associated with participants' location,
as those allocated to the intervention who lived closer to the
referral setting were less likely to accept a telephone appointment
(Azogil-López 2019) and more likely to be referred to a face-to-face
appointment from their healthcare provider (Iversen 2018). One
trial reported that participants allocated to the control group had to
travel on average 98 km to receive face-to-face care, thus indicating
that the intervention might provide particular benefits in settings
with a low-density population (Byamba 2015).
Some of the included trials were designed and implemented to
address geographical limitations on access to health care and
thus allowed for healthcare providers who were geographically
separated to exchange clinical information, promoting equity for
rural-based and other disadvantaged populations who would have
less access to healthcare. Two trials were conducted in rural
settings: South Carolina, USA (Davis 2003) and Saskatchewan,
Canada (Taylor-Gjevre 2018). Two trials recruited participants
from socio-economically disadvantaged areas (Mansberger 2015;
Sutherland 2009).
Certainty of the evidence
The included randomised trials were mostly at low or unclear risk
of selection bias. We downgraded the evidence for almost all of the
outcomes due to a high risk of performance bias, and almost half
of the trials were also at risk of detection, attrition, and reporting
biases. We also downgraded some of the evidence for imprecision,
due to the relatively small size of the trials. Our confidence in the
eFect estimates overall is moderate, although due to the relatively
low number of trials, diFerent uses of mHealth interventions and
small numbers of participants recruited there is a possibility that
the estimate of the eFect is substantially diFerent.
Potential biases in the review process
We limited the risk of publication bias by conducting a
comprehensive literature search of diFerent databases, including
published articles, clinical trials registries and unpublished
mHealth evidence. The WHO issued a call for papers through
popular digital health communities of practice to identify
additional primary trials as well as grey literature, all of which have
contributed to limit publication bias. Two review authors screened
records, extracted data and assessed the certainty of the evidence
using GRADE, with discussion with the author team whenever there
were any discrepancies.
Agreements and disagreements with other studies or
reviews
Hasselberg 2014 conducted a review on image-based medical
expert teleconsultation, with 24 studies, including non-randomised
and feasibility studies. The overall results were similar to ours.
A review on asynchronous electronic consultations that included
36 trials, seven of which were randomised trials, reported that
healthcare providers were generally satisfied with the timely
advice received and the health care provided to the participants
(Liddy 2016). When updating the review, Liddy 2019b included
non-randomised evidence and concluded that eConsults were
expanding beyond teledermatology and that providers from other
specialties were also satisfied. We found limited evidence from
randomised trials about how satisfied healthcare providers are
with mHealth to communicate with other providers. For both
reviews the authors concluded that there was limited research on
morbidity and mortality, which is consistent with our results (Liddy
2016; Liddy 2019b).
A Cochrane qualitative evidence synthesis (QES) on healthcare
providers' perceptions and experiences of using mHealth
technologies to deliver primary care healthcare services found that
while providers thought that mobile technologies improved their
work and relationships with other providers as well as participants,
they also highlighted specific challenges such as access to
electricity and network coverage (Odendaal 2020). Similarly, an
unpublished overview of factors influencing the acceptability,
feasibility and implementation of mobile health technologies also
reported problems with installation and usability, as well as issues
with electricity and connection (Glenton 2019). This is consistent
with our results, especially for settings where constant access to
electricity might be an issue (Chang 2011).
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Mobile technologies are widespread, with the quality of
transmission continuing to improve. Healthcare organisations in
a number of settings have started to provide their healthcare
providers with smartphones (Dala-Ali 2011) and healthcare
professionals oNen use their mobile phones to share clinical
information, including the transmission of images (Mobasheri
2015). This review found that mobile technologies may reduce
the time between presentation and management of the health
condition when primary care providers or emergency physicians
use them to consult with specialists, may increase the likelihood of
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receiving a clinical examination among participants with diabetes
and those who required an ultrasound and may reduce referrals to
secondary or tertiary care.
One concern that has been raised is about data-sharing and
privacy (Chang 2011; Gulacti 2017; WHO 2011). Most of the included
trials reported using secure web connections, and mobile phone
applications are being developed for secure communications
between medical staF at work. A recent review reported that
the main barriers to the adoption of mHealth by healthcare
professionals concern the perceived usefulness and ease of
use, concerns surrounding privacy, security, and technological
issues, cost, time, and how it will impact the interaction with
colleagues, patients, and management (Gagnon 2016), even in
areas where the use of mobile technologies is more common.
Training is usually required to support implementation, for instance
teledermatology has been implemented in several settings and its
optimal implementation includes training of primary healthcare
providers on how to use the mobile equipment to obtain high-
quality images (Kukutsch 2017); this was highlighted by some of the
included trials (e.g. Eminović 2009; Piette 2017).
There was little evidence about healthcare providers' satisfaction
with the intervention in the trials we identified, and although
healthcare providers reported that mobile technologies allowed
for care to be delivered more quickly and facilitated triage, one
study reported that they were less confident in their diagnosis
and management plans when using teledermatology, compared
with face-to-face care (Whited 2002). However, it is likely that
this would improve with experience. A qualitative evidence
synthesis reported that mobile technologies assisted contact with
colleagues, and recommended that healthcare providers should be
part of the planning, implementation, and evaluation of mobile
health programmes. (Odendaal 2020). Similarly, it is important to
establish whether mobile devices alleviate providers' workload, or
instead add to it, including whether there is the capacity to provide
the level of supervision and support required (Odendaal 2020).
Implications for research
• Funding is required to support the conduct of randomised trials
of mobile technology interventions in settings where these
types of intervention may have the potential to significantly
strengthen health systems, such as remote locations and where
there is a shortage of specialist services.
• Process evaluations, conducted alongside randomised trials,
to identify factors that might modify the eFect of mHealth
interventions in diFerent contexts would be a valuable addition
to the evidence base (Craig 2008). Identifying core outcomes
might be a useful step, for example, understanding the impact
of mHealth on providers' adherence to guidelines, time from
presentation to resolution, and participants' health status and
well-being are outcomes for which more evidence is required.
Research should also be conducted into consideration of factors
to support implementation, such as the high attrition rates
commonly found in studies that use mobile technologies.
• Detailed and standardised reporting of mobile health
interventions, technical features and context will contribute to
the quality of the evidence available (Agarwal 2016).
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Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Study design: Randomised trial (parallel assignment)
Unit of allocation: Participant (GP)
Participants Providers
Number: 296 participants randomised (same number ITT); number of professionals not described
Type: GPs consulting with dermatologists in secondary care
Other relevant characteristics: none reported
Participants
Number: Eligible: I: 148; C: 148 Analysed: same number (ITT)
Mean age (SD): 49 years (14)
Gender (% female): 50%
Armstrong 2018 
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Inclusion criteria: Adults diagnosed with plaque psoriasis, access to Internet and digital camera or
mobile phone with camera
Exclusion criteria: No diagnosis of plaque psoriasis, living outside the designated catchment area
Other relevant characteristics: Mainly white (63%), with college education or more (88%), and work-
ing full-time (47%). Baseline scores for severity of the condition were lower than anticipated, as several
participants were receiving other therapies
Location and study setting: USA, 3 regions
Recruitment method: Participants recruited from practice-based research networks, federally-quali-
fied health centres, and university-based clinics, national groups and general public
Duration: Number of sessions varied by participant, 12-months follow-up. Study ran between 2 Febru-
ary 2015 and 18 August 2017
Withdrawals: 6% of randomised participants were lost to follow-up and 4% withdrew
Interventions Intervention components: Online, collaborative connected-health model between participant, PCP
and dermatologist. PCP could communicate with the dermatologist using the consultation function,
sending digital photographs and clinical history for discussion. The dermatologist would assess the da-
ta and reply to the PCP within 2 business days, recommending treatment as well as educational mate-
rials for the participant. With the PCP permission, the dermatologist could also contact the participant
directly. The PCP could also request for the dermatologist to become the main HCP. All communication
was done through a secure web-based platform. Participants were paid for participating in the study,
through giN cards
Comparison: Usual care: in-person care as needed, frequency established by participants and their
providers
Technical equipment used: Secure safety policy–compliant web-based connected-health platform;
mobile phone or digital camera for collecting images
Fidelity assessment: Not reported; protocol states that protocol deviations will be noted, but not how
they will be assessed
Outcomes Main outcome: Self-reported psoriasis severity
Other outcomes: Quality of life, access to care; depression; disease severity
Time points reported: Baseline, 3-, 6-, 9-, 12-months
Notes Funding: Patient-Centered Outcomes Research Institute Award (IHS-071502-IC)
Ethical approval: Approved by university institutional review boards. Trial registry NCT02358135
Conflicts of interest: "Dr Armstrong reported serving as an investigator, consultant, advisor, and/or
speaker for AbbVie, Janssen, Lilly, Novartis, Sanofi, Regeneron, Leo, Science 37, Modmed, Pfizer, Or-
tho Dermatologics, and Modernizing Medicine. Dr Gelfand reported serving as a consultant for and re-
ceiving honoraria from BMS, Coherus (DSMB), Dermira, GSK, Janssen Biologics, Menlo Therapeutics,
Novartis Corp, Regeneron, Dr Reddy’s Laboratories, Sanofi, and Pfizer Inc; receiving research grants
(to the Trustees of the University of Pennsylvania) from AbbVie, Janssen, Novartis Corp, Regeneron,
Sanofi, Celgene, Ortho Dermatologics, and Pfizer Inc; receiving payment for continuing medical educa-
tion work related to psoriasis that was supported indirectly by Lilly, Ortho Dermatologics, and AbbVie;
and being a co–patent holder of resiquimod for treatment of cutaneous T-cell lymphoma. Dr Wong re-
ported being an employee of DirectDerm. No other disclosures were reported."
Risk of bias
Bias Authors' judgement Support for judgement
Armstrong 2018  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Comment: Computer-generated random block sizes (p.3)
Allocation concealment
(selection bias)














High risk Comment: Not possible to blind participants or personnel
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Comment: Data analyst blinded
Blinding of subjective out-
come assessment (detec-
tion bias)








Low risk Comment: Intention-to-treat analysis
Selective reporting (re-
porting bias)
High risk Comment: Not all outcomes specified in the protocol reported in publications
(distance travel, wait time)





Methods Study design: Randomised trial (parallel assignment)
Unit of allocation: Participant (GP)
Participants Providers
Number: 58 GPs randomised (31 analysed), number of hospital-based physicians not reported
Type: GPs consulting with physicians in secondary care
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Number: Eligible: I: 92; C: 164 Analysed: I: 72; C: 101
Median age: I: 56 years; C: 55 years
Gender (% female): I: 59%; C: 60%
Inclusion criteria: Adults who consulted with the GP and required a referral to secondary care
Exclusion criteria: People who required or preferred an in-person appointment
Other relevant characteristics: Not reported
Location and study setting: Spain, 6 primary care practices
Recruitment method: Not reported
Duration: Single session; 3-months follow-up. Study ran between March and December 2016
Withdrawals: 38% (N = 19) of eligible GPs were excluded from analysis (IG: 6 GPs excluded as they did
not request phone consultations with physicians; CG: 13 GPs excluded as they did not collect data for at
least 50% of their eligible participants); of those receiving care by GPs allocated to the IG, 50% were ex-
cluded from analysis as they were given in-person appointments (either because they required or pre-
ferred it)
Interventions Intervention components: If during an initial appointment the GP considered a referral for a special-
ity appointment was needed, the GP would request an eConsult with the specialist, which would take
place at the primary care practice. The GP would call the consultant at a convenient time, while the
participant was still in the room. The 2 healthcare professionals would agree on the treatment, whether
further investigations were required, and book follow-up appointments
Comparison: Usual care - participant was given a referral for an in-person appointment at secondary
care
Technical equipment used: Hands-free telephone
Fidelity assessment: Not reported
Outcomes Main outcomes: Waiting days between the GP referring the participant for an appointment and the ap-
pointment being provided; number of avoided/avoidable face-to-face referrals; waiting days for the
resolution of the process
Time points reported: Post-intervention (3-months follow-up)
Notes Funding: Andalusian Society of Family and Community Medicine -SAMFyC- (Record ref. 157/18)
Ethical approval: Regional research ethics committee. Trial registry ACTRN12617001536358
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Random-number table (p. 3)
Allocation concealment
(selection bias)
Low risk Comment: Unit of allocation was by primary care practices, and allocation was




Unclear risk Comment: Not enough information provided
Azogil-López 2019  (Continued)
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Baseline characteristics
similar (selection bias)
High risk Comment: Baseline differences between groups about participants distance to





High risk Comment: Not possible to blind participants or personnel
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Comment: Automatically extracted from the EMR (p.4)
Protection against conta-
mination








Low risk Comment: All outcomes listed in Methods reported in Results





Methods Study design: Cluster-randomised trial (parallel assignment)
Unit of allocation: Cluster (clinics)
Participants Providers
Number: 20 GPs, number of hospital-based physicians not reported
Type: GPs consulting with physicians in secondary care
Other relevant characteristics: Not reported
Participants
Number: Eligible: I: 221; C: 229 Analysed: same number
Median age: Not reported
Gender (% female): Not reported
Inclusion criteria: Adults who consulted with the GP and required a referral to secondary care for skin
lesions and problems
Exclusion criteria: Not reported
Other relevant characteristics: Not reported
Location and study setting: Mongolia, 20 rural health clinics in 1 of the least densely-population coun-
tries in the world.
Recruitment method: Not reported
Byamba 2015 
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Duration: 5-month follow-up. Study ran between September 2013 and January 2014
Withdrawals: Not reported
Interventions Intervention components: A primary care provider in a rural health clinic used a smartphone camera
to collect images and clinical history of participants with skin lesions and problems. The PCP attended
a 2-day training session to learn how to take images and use the medical record system and software
on mobile phones. The information was sent along with a teleconsultation request using the electronic
medical record. The dermatologist reviewed the information and sent feedback within 24 hours.
Comparison: Usual care - GPs referred participants to district hospitals or the National Dermatology
Centre
Technical equipment used: Android-based system
Fidelity assessment: GPs from clinics allocated to the intervention attended a 2-day training session
on how to take pictures using the devices provided and how to operate the electronic medical record
Outcomes Main outcomes: Tertiary care referrals; costs
Time points reported: Post-intervention (5-months follow-up)
Notes Funding: National science Council Project no. NSC 101-2923-E-038 -001 -MY2, Ministry of Health and
Welfare (MOHW), Taiwan, under grant MOHW103-TD-B-111-01 and Taipei Medical University under
grant 101TMUSHH-21
Ethical approval: Not reported
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Computer-generated sequence
Allocation concealment
(selection bias)




Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)





Unclear risk Comment: Not reported
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Comment: Not reported how it was collected
Protection against conta-
mination




Low risk Comment: There was no attrition
Byamba 2015  (Continued)
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Methods Study design: Cluster-randomised trial (parallel)
Unit of allocation: Cluster (10 clinics; I: 4, C: 6)
Participants Providers
Number: I: 13, C: 16
Type: Community-based peer health workers consulting with clinic staF
Other relevant characteristics: None reported
Participants
Number: Randomised: 970 (I: 446, C: 524), Analysed: ITT analysis
Median age (range): 35 years (15-76)
Gender (% female): 66%
Inclusion criteria: Adults attending eligible clinics who were receiving or started receiving ART
Exclusion criteria: None reported
Other relevant characteristics: None reported
Location and study setting: Uganda, 10 clinic sites
Recruitment method: Not applicable; participants were not informed about the study as PHWs were
performing routine care functions
Duration: Intervention lasted 26 weeks, median follow-up time was 103 weeks (97 - 111 weeks), study
was conducted between May 2006 and July 2008
Withdrawals: 11% and 12% of participants allocated to Intervention and Control were lost to fol-
low-up; main reason was death (8.3% and 10.1% of all participants lost, respectively)
Interventions Intervention components: mHealth intervention: Periodic home visits, supported by mobile phone.
PHWs participated in a 1-day residential training and were given a mobile phone and an hour-long
field-based practicum. After each home visit the PHW would message data on adherence and other
clinical information to a centralised database, which was staFed by clinic staF. Once a message had
been received, clinic staF could provide care instructions, send a higher-level care provider, or arrange
for the participant to be taken to a healthcare facility. PHWs could also call a hotline if they had ques-
tions
Comparison: No mobile phone, additional training or access to the hotline. All PHWs had previously
been enrolled in a study of ART provision, where they received a 2-day residential training on HIV-relat-
ed topics, as well as adherence counselling, patient confidentiality and filling out home visit forms. The
main goal of the home visits was to evaluate and encourage adherence to ART therapy
Chang 2011 
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Technical equipment used: mobile phones (no further details provided)
Fidelity assessment: PHWs were supervised by a member of staF (part-time worker)
Outcomes Main outcomes: Participants’ cumulative risk of virologic failure
Other outcomes: Participant adherence; virologic failure at 24 and 48 weeks of ART; lost to follow-up;
mortality; qualitative evaluation (interviews, themes included impact of the intervention, confidentiali-
ty concerns and challenges with phones); cost analyses (intervention arm only)
Time points reported: Baseline, post-intervention (median follow-up was 103 weeks post-baseline)
Notes Funding: Doris Duke Charitable Foundation, The Division of Intramural Research, The National In-
stitute for Allergy and Infectious Diseases, National Institutes of Health, and a National Institutes of
Health Training Grant and Career Development Grant
Ethical approval: Institutional review boards at the Uganda Virus Research Institute’s Safety and
Ethics Committee, the Uganda National Council for Science and Technology, and Johns Hopkins Uni-
versity
Conflicts of interest: Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Comment: Inadequate information reported, no description of sequence gen-
eration -
Quote: "The 10 sites (...) randomised 2:3 to PHWs receiving a mHealth support
intervention or not" (p.3)
Allocation concealment
(selection bias)













High risk Comment: Not possible to blind participants or personnel
Blinding of objective out-
come assessment (detec-
tion bias)




Low risk Comment: Cluster-randomised trial with participants/peer health workers




High risk Comment: High attrition rate
Selective reporting (re-
porting bias)
High risk Comment: Outcomes reported in different publications
Chang 2011  (Continued)
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Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: Two
Type: Primary care provider at the rural primary practice consulting with ophthalmologist in the uni-
versity setting
Other relevant characteristics: None reported
Participants
Number: Randomised: 59 (I: 30, C: 29), Analysed: same number
Mean age (SD): Not reported
Gender (% female): Not reported
Inclusion criteria: Adults with diabetes diagnosed by a physician
Exclusion criteria: Not reported
Other relevant characteristics: Mainly African-Americans
Location and study setting: USA, 1 rural primary practice and 1 urban university hospital
Recruitment method: Not reported
Duration: Not reported
Withdrawals: Not reported; all participants analysed
Interventions Intervention components: A primary care provider in a rural primary care practice used a nonmydri-
atic retinal camera and video-conferencing to send real-time images to an ophthalmologist located in
an urban university setting. The ophthalmologist assessed the retinal photograph and communicated
with the participant and the primary care professional
Comparison: Usual care - participants were reminded to schedule examinations with their usual eye-
care provider
Technical equipment used: nonmydriatic retinal camera (Topcon with IMAGEnet software) and video-
conferencing (no further details provided)
Fidelity assessment: Not reported
Outcomes Main outcomes: Frequency of eye examinations
Time points reported: Post-intervention
Notes Funding: Not reported
Ethical approval: Not reported
Davis 2003 
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Conflicts of interest: Not reported
Notes: short reports (letter and abstract), limited information
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Comment: Not enough information provided
Allocation concealment
(selection bias)




Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)





Unclear risk Comment: Not enough information provided
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Comment: Not enough information provided
Blinding of subjective out-
come assessment (detec-
tion bias)
Unclear risk Comment: Not enough information provided
Protection against conta-
mination




Unclear risk Comment: Not enough information provided
Selective reporting (re-
porting bias)
Unclear risk Comment: Not enough information provided





Methods Study design: Cluster-randomised trial (parallel)
Unit of allocation: Cluster (36 GP practices; I: 19; C: 17)
Participants Providers
Number: GPs: I: 59, C: 51; Dermatologists: 5
Eminović 2009 
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Type: GPs consulting with dermatologists
Other relevant characteristics: GPs: I: 29% female, C: 35% female
Participants
Number: Randomised: 631 (I: 327, C: 304), Analysed: 605 (I: 312, C: 293)
Mean age (SD): I: 42 years (23); C: 44 years (20)
Gender (% female): I: 56%; C: 64%
Inclusion criteria: Practices were required to have facilities to send digital images over the Internet;
participants were eligible if they were referred to a dermatologist by their GP
Exclusion criteria: GPs who already used teledermatology; patients were excluded if they required an
urgent dermatology appointment
Other relevant characteristics: None reported
Location and study setting: The Netherlands, 36 primary care practices
Recruitment method: Dermatologists working in eligible areas were invited to participate; GPs work-
ing in practices that referred participants to those dermatologists were then invited to participate
Duration: Intervention was 1 teleconsultation, with 1 month follow-up; study conducted between Feb-
ruary 2004 and January 2006
Withdrawals: 5% (I) and 7% (C) of participants randomised were lost to follow-up, main reasons were
problems with data entry and participants visiting another dermatologist; for 39% of participants, in-
formation on the main outcome was missing, mainly because GPs did not complete study forms
Interventions Intervention components: GPs allocated to the intervention group received detailed instructions on
how to take digital images and use the web-based form. GPs took 4 digital images of the skin problems
and completed a structured form (which included questions about duration and location of the skin le-
sion) on a secure website; the form was sent to the dermatologist along with the main reason for refer-
ral (diagnosis, advice, reassurance). At this stage GPs could also refer the participant to another derma-
tologist. Within 48 hours the dermatologist assessed the images and replied to the GP using the same
system, providing advice and whether further investigations or urgent referrals were required. After a
month the dermatologist saw the participant in person, regardless of the outcome of the online consul-
tation
Comparison: Usual care - participants saw a dermatologist according to the usual procedures, usually
by being referred by the GP who would give the participant a letter to take to the clinic
Technical equipment used: digital cameras (Kodak EasyShare CX6230 2.0 megapixel) and a secure
teledermatology website
Fidelity assessment: Not reported
Outcomes Main outcomes: Proportion of and reasons for preventable consultations
Other outcomes: Participant satisfaction in general and about interpersonal aspects of the consulta-
tion; costs
Time points reported: 1 month follow-up
Notes Funding: Senter Novem (Agency of the Dutch Ministry of Economic Affairs) and ZonMw (Dutch Organi-
zation for Health Research and Development). KSYOS Health Management Research provided the digi-
tal cameras and teleconsultation software
Ethical approval: The ethics committee deemed this study to be exempt from review because the re-
search did not interfere with usual care. Trial registration ISRCTN57478950
Eminović 2009  (Continued)
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Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Using dedicated randomisation software, practices were assigned to
teledermatologic consultation or standard care." (p.559)
Allocation concealment
(selection bias)
Low risk Quote: "A special allocation concealment procedure (...) was followed to en-




Low risk Comment: Diagnostic categories well-balanced between groups (Table 4)
Baseline characteristics
similar (selection bias)






High risk Comment: Providers could not be blinded, no information on blinding of par-
ticipants
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Comment: Not enough information provided
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Comment: Subjective assessment of whether in-person consultations could
have been prevented done by consulting dermatologist, who knew which par-
ticipants they had seen
Protection against conta-
mination
Unclear risk Comment: Treatment and diagnosis of GPs in intervention clinics may have





High risk Comment: High rate of missing data for the primary outcome
Selective reporting (re-
porting bias)
High risk Comment: Trial registration states outcomes that were not reported (diagnos-
tic accuracy, delay in treatment, learning effect GPs)
Other bias Unclear risk Comment: There were considerable problems following up participants and






Methods Study design: Randomised trial (parallel)
Unit of allocation: Participants
Participants Providers
Gulacti 2017 
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Number: Not provided
Type: Emergency physicians consulting with specialist physicians
Other relevant characteristics: Not provided
Participants
Number: Randomised: 345 (IG: 173, CG: 172), Analysed: same number
Mean age (SD): 48.5 years (22.1)
Gender (% female): 33%
Inclusion criteria: Participants: adults attending the emergency department; Physicians: owned a
smartphone and were familiarised with secure messaging applications
Exclusion criteria: Not reported
Other relevant characteristics: Not reported
Location and study setting: Turkey, 1 hospital
Recruitment method: Not reported
Duration: Intervention was consultation request using 2 different methods; study was conducted be-
tween November 2015 and February 2016
Withdrawals: No withdrawals or losses to follow-up
Interventions Intervention components: Emergency physician requested consultation with a specialist physician
using a secure messaging service (Whatsapp). Any additional medical information (e.g. blood pressure,
x-rays, ultrasounds, photographs) was sent through the same service
Comparison: Usual care; consultations were requested by telephone, with any additional medical in-
formation (e.g. blood pressure, sensory-motor findings, Glasgow Coma Score) sent verbally
Technical equipment used: Smartphone with Whatsapp (owned by the healthcare professionals)
Fidelity assessment: Not reported
Outcomes Main outcomes: Difference between groups for emergency department length of stay
Other outcomes: Difference between groups in consult time (time when consultation was requested
minus time when a bed was requested or discharge time); termination of consultation between groups
Time points reported: Baseline, post-intervention
Notes Funding: Not reported
Ethical approval: Medical Ethics Committee. Trial registry NCT02586779
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Computer programme (p.744)
Allocation concealment
(selection bias)
Unclear risk Comment: Not enough information
Gulacti 2017  (Continued)
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Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)






High risk Comment: Not possible to blind participants or healthcare professionals, even
though consulting physicians were blinded to the purpose of the study (p.744)
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Comment: Data collector was blinded (p.744)
Protection against conta-
mination
Unclear risk Comment: Healthcare professionals within the same hospital randomised and




Low risk Comment: No attrition
Selective reporting (re-
porting bias)
High risk Comment: Outcomes stated in protocol are different from outcomes reported





Methods Study design: Cluster-randomised trial (parallel)
Unit of allocation: Cluster (42 sites, 21 each arm)
Participants Providers
Number: Not reported
Type: Community nurses consulting with diabetes specialist nurses and podiatrists
Other relevant characteristics: Not reported
Participants
Number: Randomised: 182 (I: 94, C: 88), Analysed: same number
Mean age (SD): I: 67.2 years (16.7); C: 65.5 years (16.5)
Gender (% female): I: 75%; C: 74%
Inclusion criteria: Adults aged ≥ 20 years with new diabetes-related foot ulcers
Exclusion criteria: Repeated ulcer treated in the past 6 months, mental illness, life expectancy < 1 year
Other relevant characteristics: Diagnosed with diabetes for on average 20 years
Location and study setting: Norway, 2 hospitals
Iversen 2018 
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Recruitment method: Eligible patients attending 1 of 2 hospitals were invited to participate
Duration: Intervention length could vary according the clinical needs, participants seen every 6 weeks,
maximum follow-up time as 12 months; not study conducted between September 2012 and June 2016
Withdrawals: For objective measures, all participants were followed-up and included in the analysis;
for subjective measures attrition rates were 29% for the IG and 35% for the CG
Interventions Intervention components: Telemedicine application composed by a mobile phone and an interac-
tive web-based ulcer record. Consultations happened every 6 weeks and included a written assess-
ment and images taken using the mobile phone, which were then sent through the web to the special-
ist nurse or the podiatrist, who provided feedback. Any doubts could be further discussed. All staF re-
ceived training in the use of the web-based system, as well as in-person access to hospital clinics to im-
prove their practical skills
Comparison: Usual care - provided by outpatient clinic, usually scheduled every second week
Technical equipment used: Smartphone (no further description)
Fidelity assessment: Functionality was assessed yearly and minor adjustments introduced (proto-
col); all personnel received training and were following standardised guidelines for treatment of dia-
betes-related foot ulcers
Outcomes Main outcomes: Ulcer healing time
Other outcomes: Amputation; mortality; consultations; participant satisfaction; participant and
healthcare professionals' experiences (qualitative)
Time points reported: Baseline, post-intervention (12 months post-baseline)
Notes Funding: Norwegian Directorate of Health and Innovation Norway, Western Norway Regional Health
Authority, Norwegian Diabetes Association, Western Norway University of Applied Sciences, Norwegian
Research Council
Ethical approval: Western Norway Regional Committee for Medical and Health Research Ethics. Trial
registry: NCT01710774
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Randomisation using computer programme (p.97)
Allocation concealment
(selection bias)




Unclear risk Comment: Higher proportion of participants in the intervention group had ul-
cers in the toe area (60.6%) compared with control (38.6%) (p.99)
Baseline characteristics
similar (selection bias)
Unclear risk Comment: Higher proportion of participants in the intervention group had





High risk Comment: Not possible to blind participants or healthcare professionals
Iversen 2018  (Continued)
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Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Comment: Electronic records (protocol)
Blinding of subjective out-
come assessment (detec-
tion bias)












High risk Comment: Several outcomes mentioned in protocol and not reported (e.g.
quality of life, depression, anxiety)





Methods Study design: Randomised trial (parallel)
Unit of allocation: Participants (HCP)
Participants Providers
Number: Randomised: IG: 57; CG: 56
Type: Primary care practitioners consulting with specialist physicians
Other relevant characteristics: PCP practicing in Ontario and not currently using eConsult. Mostly
male (65%), 20 years since graduation
Participants
Number: Specific number of participants not reported; each PCP allocated to IG saw on average 724
participants during the pre-intervention period (range 11 to 1692), whereas those in CG saw 828 partici-
pants during the same period (range 93 to 1971)
Mean age (SD): Not reported
Gender (% female): Not reported
Inclusion criteria: Not reported
Exclusion criteria: Not reported
Other relevant characteristics: Not reported
Location and study setting: Ontario, Canada
Recruitment method: Eligible PCPs were sent an information pack and invited to participate by a third
party; those interested could get directly in touch with the research team
Duration: Trial conducted between 31 January 2014 and 26 September 2014, 12 months follow-up
from baseline
Liddy 2019a 
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Withdrawals: Approximately 12% of PCPs were not analysed at baseline and follow-up due to lack of
referral data
Interventions Intervention components: Champlain BASE™ eConsult service, a web-based application that the PCP
used to submit participant-specific clinical questions to specialists. The specialists responded within 7
days, with recommendations, further questions, or recommendation for a face-to-face referral. Special-
ists received financial incentives for each eConsult they undertook
Comparison: Usual care - standard referral practices
Technical equipment used: The application could be accessed through smartphone, laptop or desk-
top; most users accessed it through their smartphones
Fidelity assessment: Participant PCPs underwent an orientation session and brief training, without
which they could not access the system
Outcomes Main outcomes: Specialist referral rate per 100 participants seen to all medical specialties available
through eConsult service
Other outcomes: Referral rate to all medical specialties
Time points reported: Baseline, follow-up
Notes Funding: Ontario Ministry of Health and Long-Term Care (MOHLTC) and Health Services Research Fund,
Ministry Grant #06547, Province of Ontario, Primary Health Care Program (INSPRE-PHC).
Ethical approval: Hospital Research Ethics Board and the Institutional Review Board. Trial registry
NCT02053467
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Computer-generated random list of numbers ("Randomization")
Allocation concealment
(selection bias)





Low risk Comment: Baseline outcome measurements provided and similar between




Low risk Comment: Baseline characteristics provided (Table 1); differences between
groups for model of practice and practice size, practice model and location ad-





High risk Comment: Not possible due to the nature of the intervention
Blinding of objective out-
come assessment (detec-
tion bias)




Unclear risk Comment: PCPs were randomised to intervention and control groups; unclear
whether they could be located in the same practice
Liddy 2019a  (Continued)
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High risk Comment: Authors note that for missing outcomes, due to limitations relat-
ed to the use of administrative health databases, they did not end up with 50
providers per arm, resulting in an underpowered trial
Selective reporting (re-
porting bias)
Low risk Comment: Outcomes reported as per protocol





Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: Primary care professionals not reported, 2 experienced investigators
Type: Primary care professionals consulting with experienced investigators based at an eye institute
Other relevant characteristics:
Participants
Number: Randomised: 567 (I: 296, C: 271), Analysed (12 months follow-up): same number
Mean age (SD): I: 50.2 years (12.3); C: 51.7 years (11.3)
Gender (% female): I: 52%; C: 51%
Inclusion criteria: Adults diagnosed with diabetes who were scheduled to visit the primary care
provider
Exclusion criteria: Cognitive impairment
Other relevant characteristics: On average, diagnosed with diabetes for 10 years. The overall preva-
lence of diabetic retinopathy (21.5%) was lower than the national average (28.5%)
Location and study setting: USA, 2 primary care clinics
Recruitment method: Research assistants called potentially eligible patients and invited them to par-
ticipate
Duration: Follow-up lasted 48 months; not reported when study was conducted
Withdrawals: 100% response rate at 12 months follow-up, approximately 76% response rate at 48
months follow-up
Interventions Intervention components: Telemedicine - digital images were captured with a non-mydriatic camera
by clinic technicians and sent to a specialist for review and report generation. Technicians performing
imaging attended a 3-day training session to learn how to take images and ongoing feedback as need-
ed. Communication was done through private encrypted software, which transferred images and par-
ticipant data to a secure database. Experienced investigators would receive an alert once the images
were available, and grade them based on international standardised criteria, completing online re-
ports that were automatically sent to clinic staF. Participants were also encouraged to see an eye care
provider early as the camera-based exam is not considered to be a replacement for a comprehensive
eye exam. Participants received monetary incentive to complete follow-up questionnaire
Mansberger 2015 
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Comparison: Usual care - during their primary care visit, participants were encouraged to see an eye
care provider yearly. If a participant did not have an eye care provider, the primary care professional
would refer them. The study investigators contacted all the providers the participants could be referred
to, asking them to complete the same assessment forms as done for those allocated to the intervention
group. Participants in this group were also offered telemedicine screening after 48 months enrolment
Technical equipment used: Digital non-mydriatic fundus camera (model NM-1000); Internal software
for data transmission; Screen-Vu stereoscope
Fidelity assessment: Not reported
Outcomes Main outcomes: Percentage of participants receiving annual diabetic retinopathy screening examina-
tions; percentage of eyes with worsening diabetic retinopathy; percentage of telemedicine participants
who would require referral to an eye care professional for follow-up care
Time points reported: Baseline, follow-up (12, 24, 36, and 48 months post-baseline)
Notes Funding: National Eye Institute(NEI 3 K23 EY0155501-01), the Centers for Disease Control and Preven-
tion (CDCU48DP000024-01 and 1U48DP002673-01), and the Good Samaritan Foundation at Legacy
Health
Ethical approval: Institutional Review Boards of Legacy Health (Portland, OR),Oregon Health and
Science University (Portland), and the Northwest Portland Area Indian Health Board (Portland). Trial
registry: NCT01364129
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "We used a random number generator to randomly assign participants
to the telemedicine group or the traditional surveillance group" (p.519)
Allocation concealment
(selection bias)
Low risk Quote: "We used a random number generator to randomly assign participants




Unclear risk Comment: Baseline measurements relating to service use outcome (i.e. previ-
ous attendance for screening) not reported. Baseline measurements relating
to the clinical outcome (diabetic retinopathy) not reported
Baseline characteristics
similar (selection bias)






High risk Comment: No information on blinding of central study personnel; not possible
to blind primary care providers as they conducted the screening examinations;
not possible to blind participants who received examinations in different set-
tings
Blinding of objective out-
come assessment (detec-
tion bias)








Low risk Comment: Low attrition rates for first 2 data points.
Mansberger 2015  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk Comment: Telemedicine was offered exclusively to the telemedicine group
only to 2 years after recruitment. At 2 years standard-care group also offered
telemedicine. Yet follow-up of exclusive telemedicine reported only to 18
months. Outcomes for worsening retinopathy reported for intervention and
control groups combined
Other bias High risk Comment: Data collection methods differed for the 2 study groups. Whereas
outcome data (screening attendance and clinical) in the telemedicine group
were recorded by study staF (telemedical assessors, both report authors), the
study relies upon eye-care professionals in the community to report these for
the standard care group. The researchers telephoned the community eye-care
professionals to introduce the project and request their participation in com-
pleting data collection forms for the study. It is uncertain how community eye-
care professional would know who was recruited in the study. Researchers al-





Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: Not reported
Type: Home-visiting nursing staF consulting with a hospital physician
Other relevant characteristics: Not reported
Participants
Number: Randomised: 188 (I: 100, C: 88), Analysed: unclear
Mean age (SD): I. 86.5 (7.0), C: 84.4 (7.1)
Gender (% female): I: 72%; C: 76%
Inclusion criteria: Adults aged ≥ 65 years, attending the Department of Clinical Nutrition, treated with
home enteral nutrition
Exclusion criteria: Not reported
Other relevant characteristics: Most had multiple morbidities
Location and study setting: Italy, 1 hospital
Recruitment method: Not reported
Duration: Intervention lasted 12 months; study conducted between January and December 2013
Withdrawals: 38% and 33% of participants were lost to follow-up (I and C, respectively), reasons not
provided
Interventions Intervention components: Usual care plus video consultation - during the monthly home visits, the
home-visiting staF called the hospital physician using the tablet. The latter would visually examine the
participant for different clinical signs (e.g. hydration, oedema). Video calls lasted on average 2 minutes.
If necessary, nutrition and pharmacological therapy would be adjusted
Orlandoni 2016 
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Comparison: Usual care - regular monthly home visits done by nurses to perform scheduled evalua-
tions, which included an electrocardiogram, pulse oximetry, and blood glucose and pressure measure-
ment. Data collected were logged online and reviewed by the hospital physician 2 to 3 days after the
visit
Technical equipment used: Tablet (Samsung Galaxy)
Fidelity assessment: Video-consultation followed a specific protocol; no further details provided
Outcomes Main outcomes: Frequency and type of complications; frequency and reason for outpatient visits and
hospitalisations; modification of nutrition therapy; frequency and duration of video-consultations (in-
tervention group only)
Time points reported: Baseline, follow-up (12 months post-baseline)
Notes Funding: Not reported
Ethical approval: Hospital Ethics Committee
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Block randomisation (...) was carried out by the statistical service of
[the hospital] using computer-generated allocation" (p.763)
Allocation concealment
(selection bias)




Low risk Comment: Baseline medical measurements that could impact the clinical out-
come (main indicators of nutritional status, comorbidities, general health sta-
tus) reported and similar between groups (Table 1)
Baseline characteristics
similar (selection bias)
Low risk Comment: Baseline characteristics provided and overall similar between






High risk Comment: Not possible to blind participants and personnel
Blinding of objective out-
come assessment (detec-
tion bias)
High risk Comment: Main outcome is overall complications. The home-visit staF, who
were not blinded, collected the outcome data
Protection against conta-
mination
Unclear risk Comment: Contamination between groups is possible as all home-visiting staF




High risk Comment: High rates of attrition, not explained
Selective reporting (re-
porting bias)
Low risk Comment: All outcomes presented in the Methods are reported in the Results
Other bias Low risk Comment: No other apparent source of bias
Orlandoni 2016  (Continued)
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Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: Not reported
Type: Primary care professional consulting with dermatologist
Other relevant characteristics: Not reported
Participants
Number: Randomised: 698 (I: 351, C: 347), Analysed: 508: 236 in usual care and 272 in teledermatology
Mean age (SD): I: 43.6 years; C: 46.8 years
Gender (% female): I: 71%; C: 66%
Inclusion criteria: Adults referred from Department of Defence primary care clinics
Exclusion criteria: Urgent condition, multiple complaints
Other relevant characteristics: Mainly white
Location and study setting: USA, 4 primary care clinics (Department of Defence owned)
Recruitment method: Eligible participants were invited to participate
Duration: Single consultation with 4 months follow-up; not reported when study was conducted
Withdrawals: 33% of randomised participants did not complete follow-up: 15% were withdrawn,
mainly due to deployment or loss of privileges; 6% withdrew, mainly due to resolution of skin problem;
4% could not be contacted and were lost to follow-up
Interventions Intervention components: A teledermatology appointment was scheduled, unclear how this was
done. A dermatologist would then review the consultation and the images, and could either schedule a
face-to-face appointment with the participant or send a diagnosis and management plan to the prima-
ry care professional
Comparison: Usual care - a dermatology appointment was scheduled at a clinic
Technical equipment used: Digital camera (Coolpix 990, 3.3 megapixel); images were transferred us-
ing a web-based secure server purposively developed
Fidelity assessment: Data
Outcomes Main outcomes: Clinical improvement based on serial cutaneous examination; costs
Time points reported: Baseline, post-intervention (4 months post-baseline)
Notes Funding: Telemedicine and Advanced Technology Research Center
Ethical approval: Appropriate committees
Conflicts of interest: "HSP is Chairman and Co-founder of TeledermSolutions, Inc., a Web-based tele-
dermatology consultation service, is Co-editor of Teledermatology: A user’s guide, published by Cam-
bridge University Press, and is slated to receive royalties based on sales. JDW is Co-editor of Teleder-
Pak 2007 
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matology: A user’s guide, published by Cambridge University Press, and is slated to receive royalties
based on sales."
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Authors report that block randomisation was used (p.27)
Allocation concealment
(selection bias)
Low risk Comment: Following informed consent the sealed envelope was opened to re-




Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)
High risk Comment: Partciipants allocated to the control group were older than those





High risk Comment: Not possible to blind participants or personnel as care pathway was
different
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Comment: Calculated using repayment rates
Blinding of subjective out-
come assessment (detec-
tion bias)









High risk Comment: High attrition rates
Selective reporting (re-
porting bias)
High risk Comment: Outcomes reported in different papers





Methods Study design: Cluster-randomised trial (parallel assignment)
Unit of allocation: Cluster (8 primary care practices, 4 allocated to the intervention group and 4 allo-
cated to the control group)
Participants Providers
Number: 39 GPs, 3 dermatologists
Piette 2017 
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Type: GPs consulting with dermatologists
Other relevant characteristics: Not reported
Participants
Number: Randomised: 109 (I:55, C:54), Analysed: 103 (I:53, C:50)
Mean age: I: 44 years; C: 43.5 years
Gender (% female): I: 70%; C: 50%
Inclusion criteria: Adults with a skin condition for which the GP required a dermatologist's advice
Exclusion criteria: Urgent medical care
Other relevant characteristics: Not reported
Location and study setting: France, 8 urban primary care practices
Recruitment method: Participants identified by the GPs and invited to participate
Duration: Single session; 90 days follow-up
Withdrawals: 5.5% of participants were excluded after being assessed as eligible (reasons provided)
Interventions Intervention components: GPs received training and a workbook on how to take photographs (p.2,
top 2nd column). GPs took at least 3 photos of skin lesions and sent them with a standardised written
message (date of symptoms, symptomatology, topography, description and extension of lesions, drug
intake) through secure e-mail to dermatologists. Dermatologists provided a diagnosis or possible dif-
ferential diagnoses, and if necessary a management plan, which was implemented by the GP. The der-
matologists could also book an appointment to see the participant in person
Comparison: Usual care - participants were given a standardised printed referral letter, which they
could use to book an appointment with a dermatologist
Technical equipment used: Photos were taken using either a mobile phone or digital camera (mini-
mum 3 megapixels)
Fidelity assessment: GPs received 2 hours training on how to take photos and were given a workbook
explaining the detailed procedures to take photos compliant with the American Telemedicine Associa-
tion recommendations
Outcomes Main outcomes: Days lapsed between the GP’s consultation and the dermatologist’s reply that al-
lowed for the GP to begin treatment; participant's satisfaction; physicians' and participants' satisfac-
tion; number of non-usable photographs taken
Time points reported: Post-intervention (3 months post-baseline)
Notes Funding: Pole de Santé Universitaire Gennevilliers Villeneuve la Garenne
Ethical approval: Hospital Institutional Review Board. Trial registry: NCT02122432
Conflicts of interest: None known
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Computer-generated random list (p.2)
Piette 2017  (Continued)
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Allocation concealment
(selection bias)
Low risk Comment: Investigator generated the list at the start of the study for all prima-





Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)
High risk Comment: Baseline characteristics provided, groups different for sex distribu-





High risk Comment: Participants, GPs, and study personnel were not blinded to group
allocation (p.2)
Blinding of objective out-
come assessment (detec-
tion bias)
High risk Comment: Days between consultations reported by the participant, who was
not blinded to group allocation
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Comment: Reported by GPs and participants who were not blinded to group
allocation, and dermatologists (intervention group only)
Protection against conta-
mination




Low risk Comment: Low attrition rates (Figure 1)
Selective reporting (re-
porting bias)
Low risk Comment: All outcomes specified in the protocol were reported in the pub-
lished article





Methods Study design: Randomised trial (cross-over)
Unit of allocation: Participant
Participants Providers
Number: 8 emergency department (ED) residents
Type: ED residents consulting with consultants
Other relevant characteristics: Not reported
Participants
Number: Not reported
Mean age (SD): Not reported
Riordan 2015 
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Gender (% female): Not reported
Inclusion criteria: Adults attending the ED
Exclusion criteria: Not reported
Other relevant characteristics: Not reported
Location and study setting: USA, 1 ED
Recruitment method: Not reported
Duration: Single consultation with 1 month follow-up; not reported when study was conducted
Withdrawals: Not reported
Interventions Intervention components: Electronic consultation application, used by the ED resident to communi-
cate with consultants
Comparison: Usual care
Technical equipment used: Tablets (iPad)
Fidelity assessment: Not reported
Outcomes Main outcomes: Conciseness; pertinence of information presented; flow; effectiveness of communica-
tion skills; overall quality of physician to physician consultations
Time points reported: Post-intervention (1 month post-baseline)
Notes Funding: Not reported
Ethical approval: Not reported
Conflicts of interest: Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Comment: Not enough information provided
Allocation concealment
(selection bias)




Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)





Unclear risk Comment: Not enough information provided
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Comment: Not enough information provided
Riordan 2015  (Continued)
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Blinding of subjective out-
come assessment (detec-
tion bias)
Unclear risk Comment: Not enough information provided
Protection against conta-
mination




Unclear risk Comment: Not enough information provided
Selective reporting (re-
porting bias)
Unclear risk Comment: Not enough information provided





Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: 1 primary care physician, 6 radiologists
Type: Primary care physician consulting with radiologists
Other relevant characteristics: Primary care physician received sonographic training at 3 US medical
centres
Participants
Number: Randomised: 105 (I: 53, C: 52), Analysed: same number
Mean age (SD): I: 27 years; C: 29 years
Gender (% female): I: 90; C: 94%
Inclusion criteria: Participants aged ≥ 13 years attending a primary care clinic, with symptoms requir-
ing a trans-abdominal or trans-vaginal ultrasound
Exclusion criteria: Not reported
Other relevant characteristics: Low-income setting
Location and study setting: Dominican Republic, 1 rural clinic
Recruitment method: All eligible patients were invited to participate
Duration: Intervention was 1 consultation; not reported when study was conducted
Withdrawals: No withdrawals
Interventions Intervention components: Primary care professional performed scans according to current practice
guidelines, which were then emailed to US-based radiologists along with forms with any relevant clini-
cal information. The on-site investigator received sonographic training over a 2-month period, as well
as practice guidelines for trans-abdominal ultrasound scanning. The radiologists interpreted the scans
Sutherland 2009 
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and returned the forms, along with an assessment of the scan's quality. Participants were instructed to
return to the primary care clinic within 48 hours
Comparison: Usual care - received regular ultrasound referral and were instructed to return the diag-
nostic report in hand as soon as possible
Technical equipment used: Portable ultrasound scanner (SonoSite Titan with 5.2 MHz curvilinear
transducer), images sent by email as attachment
Fidelity assessment: Not reported
Outcomes Main outcomes: Time to final diagnosis; time to follow-up appointments; number of successful fol-
low-ups; number of delivered reports
Time points reported: Post-intervention
Notes Funding: Global Health Leadership Fellowship, sponsored by the Edward Via Virginia College of Osteo-
pathic Medicine
Ethical approval: Appropriate ethics committee
Conflicts of interest: Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Comment: Coin tossing (p.192)
Allocation concealment
(selection bias)




Unclear risk Comment: Not enough information provided
Baseline characteristics
similar (selection bias)





High risk Comment: Only 1 primary care physician, not possible to blind; participants
were aware of group allocation as it implied different actions
Blinding of objective out-
come assessment (detec-
tion bias)








Low risk Comment: No attrition
Selective reporting (re-
porting bias)
Low risk Comment: All outcomes mentioned in the Methods are reported in the Results
section
Other bias Low risk Comment: No other apparent risk of bias
Sutherland 2009  (Continued)
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Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number:
Type: 3 rural-based physical therapists consulting with 3 urban-based rheumatologists
Other relevant characteristics: Not reported
Participants
Number: Randomised: 85 (I: 54, C: 31), Analysed: 54 (I: 31, C: 23)
Mean age (SD): I: 58.4 years (10.7); C: 53.1 years (12.2)
Gender (% female): I: 80%; C: 81%
Inclusion criteria: Adults with a clinical diagnosis of rheumatoid arthritis, living more than 100 km
away from the urban centres
Exclusion criteria: Not reported
Other relevant characteristics: Mean duration of rheumatoid arthritis was 1.9 years
Location and study setting: Canada, 1 urban clinic, 5 rural clinics
Recruitment method: Identified through the clinic databases
Duration: Intervention was 1 consultation every 3 months, follow-up lasted 9 months; not reported
when study was conducted
Withdrawals: 43% (I) and 26% (C) of participants did not complete the study; main reason provided by
participants allocated to the intervention group was a preference for travelling into town for their ap-
pointment
Interventions Intervention components: Video-consultations between physical therapist and rheumatologist;
the participants were present for part of the consultation, during which they were examined by the
rheumatologist. Physical therapists and rheumatologists received an orientation and education ses-
sion about rheumatoid arthritis and the study protocol and methods
Comparison: Usual care - in-person rheumatology clinics
Technical equipment used: Laptops with video-conferencing software (VidyoDesktop software); de-
tachable external web camera with remote pan, tilt and zoom functions
Fidelity assessment: All healthcare professionals attended an education session about the study pro-
tocol
Outcomes Main outcomes: Disease activity metrics; health assessment; participant satisfaction
Time points reported: Baseline, post-intervention (9 months post-baseline)
Notes Funding: Canadian Initiative for Outcomes in Rheumatology cAre (CIORA)
Ethical approval: University of Saskatchewan Biomedical Research Ethics Board; trial registry
NCT02371915
Taylor-Gjevre 2018 
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Conflicts of interest: Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "[S]tratified block randomisation algorithm" (p.2)
Allocation concealment
(selection bias)
Low risk Quote: "Clinicians were not involved in or aware of the outcome of the ran-













High risk Comment: Due to the nature of the intervention participants and personnel
could not have been blinded and no attempts at blinding were described
Blinding of objective out-
come assessment (detec-
tion bias)
High risk Comment: Physical examination data were collected by on-site physical thera-
pists and by urban rheumatologists, due to the nature of the intervention they
could not have been blinded
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Comment: Self-reported outcomes were quality of life and satisfaction with
care, and participants were not blinded
Protection against conta-
mination





High risk Comment: High attrition rates
Selective reporting (re-
porting bias)
High risk Comment: Reports all outcomes mentioned in Methods section of paper, but
not all outcomes stated in online trial record (NCT02371915), e.g. change in
healthcare use





Methods Study design: Cluster-randomised trial (parallel)
Unit of allocation: Cluster (47 primary care practices, 23 allocated to the intervention group and 24 to
the control group)
Participants Providers
Number: 128 GPs (number of nephrologists not provided)
Van Gelder 2017 
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Type: GPs consulting with nephrologists
Other relevant characteristics: Not reported
Participants
Number: I: 1277; C: 1727
Mean age (SD): I: 68.0 years (13.6); C: 66.4 years (13.2)
Gender (% female): I: 67%; C: 65%
Inclusion criteria: Adults with a clinical diagnosis of chronic kidney disease who qualified for consulta-
tion or referral to nephrology specialist care
Exclusion criteria: Receiving secondary renal care
Other relevant characteristics: Most had at least 1 comorbid chronic condition
Location and study setting: The Netherlands, 47 primary care practices across the country
Recruitment method: GPs were invited to participate while attending a CKD management course; eli-
gible patients were identified through EMR
Duration: Intervention was implemented between March 2011 and June 2012; follow-up duration un-
clear
Withdrawals: Approximately 3% of eligible patients did not start the trial (reasons provided); 7.7% of
participants did not complete follow-up (deceased: n = 181; moved: n = 50; unknown: n = 1)
Interventions Intervention components: Telenephrology was added to the EMR as an add-on application, which
was activated by the GP for each specific participant. The nephrologist was then notified about the
consultation by e-mail or text message and advised the GP about further treatment required, including
referrals if needed
Comparison: Usual care - conventional consultation methods
Technical equipment used: Encrypted EMR, accessed with a direct single sign-on
Fidelity assessment: Not reported
Outcomes Main outcomes: Difference in referral rate between intervention and control groups
Other outcomes: Difference in consultation rates by telephone or telenephrology; adherence to
the advised monitoring criteria; GP's compliance with coding renal impairment as a separate entity;
achievement of blood pressure targets; main related medical costs; incidence of CKD; GPs experience
with using telenephrology
Time points reported: Unclear
Notes Funding: Dutch Kidney Foundation and Amgen
Ethical approval: Not required according to the accredited Medical Research Ethics Committee Arn-
hem/Nijmegen. Clinicians and participants were informed electronic medical data were being used for
research purposes and could opt-out. Netherlands Trial Registration 2242
Conflicts of interest: "The Department of Primary and Community Care received a non-conditional
grant from Amgen. Jack Wetzels received research grants from Amgen, Genzyme and Pfizer for the Mas-
terplan study. All other authors have no conflicting interests"
Risk of bias
Bias Authors' judgement Support for judgement
Van Gelder 2017  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Comment: Stratified block randomisation (p.432)
Allocation concealment
(selection bias)
Low risk Comment: Independent statistician performed randomisation by institution at




Unclear risk Comment: Not enough information provided to make a decision
Baseline characteristics
similar (selection bias)






High risk Comment: Due to the nature of the intervention participants and personnel
could not have been blinded and no attempts at blinding were described
Blinding of objective out-
come assessment (detec-
tion bias)
High risk Comment: All referrals were reported by both the GPs and the nephrologists in
an online survey system
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Comment: GPs in the intervention group answered a survey about their experi-
ence with the intervention (p.432)
Protection against conta-
mination





Low risk Comment: Low attrition rates
Selective reporting (re-
porting bias)
Low risk Comment: All outcomes specified in the protocol were reported in the pub-
lished article





Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: 60 GPs, 8 dermatologists
Type: GPs consulting with dermatologists
Other relevant characteristics: Dermatologists were mainly third-year residents
Participants
Number: Randomised: 274 (I: 134, C: 140), Analysed: ITT analysis
Whited 2002 
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Mean age (SD): I: 60.9 years (7.8); C: 66.9 years (8.5)
Gender (% female): 5%
Inclusion criteria: Adults referred to the Dermatology service from primary care clinics
Exclusion criteria: Urgent conditions that required immediate attention
Other relevant characteristics: Mainly white
Location and study setting: USA, 4 clinics at a Veteran Affairs Medical Centre
Recruitment method: Not reported
Duration: 1 consultation/referral; not reported when study was conducted
Withdrawals: Not reported
Interventions Intervention components: GPs submitted digital images of skin lesions with a standardised medical
history and any additional relevant information. The consultant dermatologist reviewed all the data
and replied either by scheduling a clinic-based appointment or sending a diagnosis and management
plan to the GP, without further need for a clinic-based appointment
Comparison: Usual care - GPs referred participants to the dermatology service as needed
Technical equipment used: Fujix DS-515 digital camera
Fidelity assessment: As a quality-control measure, images were assessed on a laptop computer while
acquiring them
Outcomes Main outcomes: Time to intervention; costs; participant and healthcare professional satisfaction
Time points reported: Baseline, resolution of the problem (variable)
Notes Funding: VA Health Services Research and Development Service and VA Health Services Research and
Development Service
Research Career Development Award
Ethical approval: Research and Development Committee and the Human Studies Subcommittee of
the Department of Veterans Affairs Medical Center, Durham, North Carolina
Conflicts of interest: Not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Comment: Not enough information provided
Allocation concealment
(selection bias)
Low risk Quote: "Referring primary care clinicians contacted the research assistants
during the course of clinic visits when a dermatology consult was consid-
ered appropriate. Research assistants were blinded to the study arm in which




Low risk Comment: Lesion characteristics were similar between groups (Table 2)
Baseline characteristics
similar (selection bias)
Unclear risk Comment: Baseline characteristics reported and similar between groups (Ta-
ble 2)
Whited 2002  (Continued)
Mobile technologies to support healthcare provider to healthcare provider communication and management of care (Review)















High risk Comment: Not possible to blind participants and personnel
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Quote: "Research assistants were blinded to the study arm in which prospec-
tive patients were randomised." (p.314)
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Comment: Self-reported satisfaction
Protection against conta-
mination
Unclear risk Comment: Contamination unlikely to be a risk at participant level. Risks of or





Low risk Comment: Data analysed for all participants
Selective reporting (re-
porting bias)
High risk Comment: Different outcomes reported in different publications





Methods Study design: Randomised trial (parallel)
Unit of allocation: Participant
Participants Providers
Number: Not reported
Type: GPs consulting with dermatologists
Other relevant characteristics: Not reported
Participants
Number: Randomised: 392 (I: 196, C: 196), Analysed: 261 (I: 136; C: 125)
Mean age (SD): I: 62.9 years (13.9); C: 61.7 years (14.9)
Gender (% female): 2% (Veteran Affairs clinics)
Inclusion criteria: Adults referred to the Dermatology service from primary care clinics
Exclusion criteria: More than 1 skin condition, required full-body examination, could not read or speak
English, low health literacy
Other relevant characteristics: Mainly white
Location and study setting: USA, 2 outpatient community-based Veteran Affairs clinics
Whited 2013 
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Recruitment method: Eligible participants were identified whenever the GP generated a request for a
consultation with the dermatology department
Duration: 1 consultation/referral (unless participant required further treatment), 9 months follow-up;
study conducted between November 2008 and March 2011
Withdrawals: 33% of participants randomised did not complete follow-up (reasons provided, similar
numbers for I and C)
Interventions Intervention components: Alongside the request for a referral, GPs submitted digital images of skin
lesions with a standardised medical history and any additional relevant information. The consultant
dermatologist reviewed all the data and replied either by scheduling a clinic-based appointment or
sending a diagnosis and management plan to the GP, without further need for a clinic-based appoint-
ment
Comparison: Usual care - GPs referred participants to the dermatology service as needed using the
electronic medical record
Technical equipment used: 8-megapixel digital camera with an integrated flash; if required, digital
ring flash for short focal length or macro images
Fidelity assessment: Imaging protocol
Outcomes Main outcomes: Quality of life; health status; comorbidity assessment; cost; satisfaction with care
Time points reported: Baseline, follow-up (3 and 9 months post-baseline assessment)
Notes Funding: US Department of Veterans Affairs Health Services Research and Development Service; Na-
tional Institutes of Health
Ethical approval: Approved by institutional review boards. Trial registry: NCT00488293
Conflicts of interest: "Drs Whited and Edison are coeditors of the book Teledermatology: A User’s
Guide published by Cambridge University Press and receive royalties based on sales. Dr Chren is a con-
sultant to Genetech Inc (on patient-reported outcomes)."
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Comment: Simple randomisation scheme stratified by site (p.586)
Allocation concealment
(selection bias)














High risk Comment: Not possible due to the nature of the intervention
Whited 2013  (Continued)
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Blinding of objective out-
come assessment (detec-
tion bias)
High risk Comment: Costs partially calculated based on site reports, which are variable;
clinical staF not blinded to group allocation
Blinding of subjective out-
come assessment (detec-
tion bias)




Unclear risk Comment: Contamination unlikely to be a risk at participant level. Risks of or









High risk Comment: Outcomes differ between protocol and publications
Other bias Low risk Comment: No other apparent risk of bias
Whited 2013  (Continued)
Empty cells in the "Risk of bias" tables refer to instances where the specific risk of bias criterion did not apply, e.g. the type of outcome
was not collected by the study.
ART: Antiretroviral Therapy; C: Control; CKD: Chronic kidney disease; EMR: Electronic medical record; GPs: General practitioners; HCP:
Healthcare provider; HEW: Health extension workers; I: Intervention; PCP: Primary care provider; PHWs: Peer health workers; VA: Veteran
AFairs
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Ateudjieu 2014 Compares in-person supervision with automated text messages
Atnafu 2017 Mobile technologies used for emergency referrals, not seeking guidance or providing care
Batista 2016 Not mobile
Bettinelli 2015 Feasibility study
Burns 2016 Not mobile (desktop video-conferencing system)
Buvik 2016 Not mobile (desktop personal computers)
Chiaravalloti 2017 Pilot study
Conlin 2006 Not an intervention study (diagnostic accuracy)
Da Silva 2018 Not mobile
Ferrándiz 2017 Compares 2 Internet-based interventions (clinical images vs. dermoscopic images)
Golberstein 2017 Not mobile (desktop personal computers)
Gong 2018 Multifaceted study with several components
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Study Reason for exclusion
Haridy 2017 Pilot study
Loane 2001 Not mobile (desktop video-conferencing telephone)
NCT02710799 Not mobile
Nwando Olayiwola 2016 Not mobile (desktop personal computers, as well as laptops)
Oakley 2000 Not mobile (desktop personal computers)
Owen 2019 Feasibility study
Phillips 2019 Mainly educational
Pryzbylo 2014 Compares 2 devices (smartphone and pager) for routine communication
Romero 2009 Diagnostic accuracy study
Wesarg 2010 Compares 2 methods for fitting a Cochlear device, each participant has the device fitted remotely
or face-to-face (not randomised)
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name Establishing the role of teleconsulting in the care of chronic conditions in rural areas of the South-
ern District Health Board (SDHB): A randomised controlled trial (RCT) in patients with Inflammatory
Bowel Disease
Methods Randomised trial, parallel assignment, open-label
Participants Adults aged ≥ 18 years diagnosed with irritable bowel syndrome living in rural settings
Interventions Intervention: remote consultation through teleconference with nurse facilitation
Comparison: usual care
Outcomes Main outcomes: disease control; disease-specific quality of life
Other outcomes: cost effectiveness; acceptability
Starting date April 2017 (expected completion date June 2020)





Study name A prospective randomised controlled study of telehealth specialist palliative care consultations in
rural and metropolitan settings and the impact on patient and carer clinical outcomes and quali-
ty-of-life
ACTRN12618001007224 
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Methods Randomised trial, parallel assignment, open-label
Participants Adults aged ≥ 18 years receiving community, inpatient or outpatient palliative care
Interventions Intervention: in-home consultation through teleconference with nurse facilitation
Comparison: usual care
Outcomes Main outcomes: clinical symptoms; quality of life; performance status
Other outcomes: emergency department attendances; time to set up teleconference equipment;
user experience; home visit duration; other participant-reported symptoms
Starting date June 2018 (expected completion date October 2020)





Study name Teledermatology mobile apps: implementation and impact on veterans' access to dermatology
Methods Randomised trial, cross-over assignment, open-label
Participants All people receiving dermatology care at eligible clinics
Interventions Intervention: Tablet loaded with app, which allows to capture and immediately upload images in-
to the electronic records system, where it can be reviewed by referring providers and imagers
Comparison: Usual care (for 3-month blocks, until they also start using the app)
Outcomes Main outcomes: consult completion time; appointment completion time; number of teledermatol-
ogy appointments; fraction of appointments using teledermatology; travel distance
Other outcomes: none specified
Starting date March 2019 (estimated completion date September 2020)






Methods Randomised trial, parallel assignment, open-label
Participants People with metastatic cancer or haematological malignancy being treated with oral therapy, aged
≥ 18 years
Interventions Intervention: Participants will be given access to nurse navigators and a web portal, which will al-
so be used for nurses to communicate with other healthcare professionals
Gervès-Pinquié 2017 
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Comparison: Usual care
Outcomes Main outcomes: relative dose intensity
Other outcomes: compliance; toxicity
Starting date October 2016 (estimated completion date October 2020)
Contact information Marie Ferrua (marie.ferrua@gustaveroussy.fr)




Study name Evaluation of the DIABEO system in poorly controlled DM1 or DM2 patients treated with a basal-bo-
lus insulin regimen
Methods Randomised trial, parallel assignment, open-label
Participants People aged ≥ 18 years with Type 1 or Type 2 diabetes
Interventions Intervention: Participants are provided with an electronic diary system for monitoring glycaemic
levels; results are uploaded to an online portal that can be accessed by HCP; clinical information
can be exchanged between different HCPs
Comparison: Usual care
Outcomes Main outcomes: change in HbA1c
Other outcomes: HbA1c levels; percent of responder participants; severe hypoglycaemia
Starting date February 2013 (estimated completion date July 2018)
Contact information Sylvia Franc





Study name TeleDerm study
Methods Cluster-randomised trial, parallel assignment, open-label
Participants Adults with a dermatologic problem and insured by a specific health insurance company
Interventions Intervention: When faced with a dermatologic case, the GP can trigger a teleconsultation process
with a dermatologist, based on high-resolution pictures and clinical history
Comparison: Usual care
Outcomes Main outcomes: Number of physical referrals to dermatologists
Koch 2018 
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Other outcomes: Referral time; process quality; health-related quality of life; costs
Starting date July 2018 (expected completion date June 2019)
Contact information Roland Koch (roland.koch@med.uni-tuebingen.de)





Methods Randomised trial (cluster parallel)
Participants Community health workers (CHWs) working in districts with Integrated Community Case Manage-
ment (Uganda and Mozambique)
Interventions CHWs are equipped with smartphones that can be used to facilitate decision-making, submit data,
receive personal performance feedback and communicate with their supervisor
Outcomes Main outcome: appropriate treatment of malaria, pneumonia and diarrhoea in children under 5
years of age at 12 months
Other outcomes: CHWs with medicine stock-out < 1 week each quarter; CHW retention
Starting date April 2013
Contact information Karen Kalländer




Study name Screening of cardiovascular, cerebrovascular, and renal disease for residents in rural areas using a
medical IT network
Methods Randomised trial, parallel assignment, open-label
Participants Adults aged ≥ 65 years living in rural areas, with low-to-moderate risk of cardiovascular disease
Interventions Intervention: Using clinical data from a medical information network, specialists in cardiology,
nephrology and cerebrovascular disease assess patient data and make treatment recommenda-
tions to GPs
Comparison: Usual care, participants are treated in-person by physician
Outcomes Main outcomes: Incidence of cardiovascular, cerebrovascular, or renal disease
Other outcomes: Not reported
Starting date May 2015 (no information about study completion)
Contact information Masaharu Nakayama (nakayama@cardio.med.tohoku.ac.jp)
Nakayama 2016 
Mobile technologies to support healthcare provider to healthcare provider communication and management of care (Review)










Cochrane Database of Systematic Reviews





Study name The impact of Telemedicine to support palliative care resident in nursing home (TELESM)
Methods Randomised trial, parallel assignment, open-label
Participants Nursing home residents aged ≥ 65 years, with palliative care needs
Interventions Intervention: Telemedicine consultation - multi-professional consultation with healthcare profes-
sionals (participant and their families can also participate if desired)
Comparison: Usual care
Outcomes Main outcomes: hospitalisation rates
Other outcomes: emergency hospitalisation rates; proportion of hospitalised participants; quality
of life; caregiver satisfaction; costs
Starting date January 2018





Study name Evaluation of the management of diabetic foot ulcers by telemedicine on the number of hospital
days in diabetic patients (TELEPIED)
Methods Randomised trial, parallel assignment, open-label
Participants Patiients with diabetes and foot ulcer aged ≥ 18 years
Interventions Intervention: During home visits the community nurse will photograph foot ulcers, which will be
sent to the specialist nurse for assessment and follow-up
Comparison: Usual care
Outcomes Main outcomes: number of hospitalisation days due to diabetic foot ulcers
Other outcomes: total direct care costs; average duration of hospitalisation due to diabetic foot ul-
cers; ulcer recidivism rate; frequency of ulceration; duration of ulceration; healing rate; amputation
rate; participant satisfaction score
Starting date January 2017 (estimated completion date January 2021)
Contact information Sylvia Franc (sylvia.franc@free.fr)
Notes  
NCT02986256 
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Study name OASE Melanome
Methods Cluster-randomised trial, open-label
Participants Adults aged ≥ 18 years consulting a GP for a suspicious cutaneous lesion who require a referral to a
dermatologist
Interventions Intervention: The GP sends the dermatologist 2 photos of skin lesions, along with relevant clinical
information, after which the dermatologist assesses the photos and follows up with the participant
as required
Comparison: Usual care
Outcomes Main outcomes: Time limit between consultation with GP and consultation with dermatologist
Other outcomes: Proportion of participants who did have a consultation with a dermatologist 12
months after consulting with GP
Starting date May 2017 (estimated completion date May 2018)
Contact information Jean-Michel Nguyen (jeanmichel.nguyen@chu-nantes.fr)




Study name Effectiveness of collaborative tele-mental health services for ADHD in primary care: a randomised
trial in Dubai (ECTSAP- Dubai Trial)
Methods Randomised trial, parallel assignment, open-label
Participants Children aged 6 to 12 years diagnosed with attention deficit hyperactivity disorder (ADHD)
Interventions Intervention: remote consultation through teleconference with specialist supervision
Comparison: usual care
Outcomes Change in clinical symptoms
Starting date June 2018 (expected completion date December 2018, personal communication with principal in-
vestigator 22 October 2019 confirmed it is ongoing)





Study name Addressing early childhood hearing loss in rural Alaska: a community randomised trial
Methods Randomised trial, parallel assignment, single masking (outcomes assessor)
NCT03662256 
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Participants Children aged 2 to 6 years, attending eligible schools
Interventions Little information provided; intervention described as telemedicine referral and mHealth screening
tool
Outcomes Main outcomes: time to diagnosis
Other outcomes: sensitivity and specificity of screening protocols; prevalence of hearing loss
Starting date September 2018 (estimated completion date February 2020)





Study name Telemedical support for prehospital Emergency Medical Service (TEMS)
Methods Randomised trial, parallel assignment, open-label
Participants All emergency calls that are assessed as non-life-threatening, which do not require an obligatory
emergency medical service physician on scene and which do not solely require an ambulance
staFed by paramedics
Interventions Intervention: Tele-EMS physician - participants are treated by the paramedics, who will be sup-
ported by the tele-EMS physicians based at a teleconsultation centre
Comparison: Usual care, participants are treated by physician on scene
Outcomes Main outcomes: adverse events
Other outcomes: adherence to guidelines; quality of medical history; completeness and correct-
ness of data; tracer diagnoses; mortality; intensive care unit length of stay; hospital length of stay;
other outcomes
Starting date July 2017 (estimated study completion date December 2019)





Study name A coordinated PCP-cardiologist telemedicine model (PCTM) in China's community hypertension
care
Methods Randomised trial, parallel assignment, open-label
Participants Adults aged ≥ 21 years, with a clinical diagnosis of hypertension with uncontrolled blood pressure
in the past 3 months, currently taking or about to take anti-hypertensive medications
Xu 2017 
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Interventions Intervention: Participants are given a blood pressure monitoring system for self-management,
which feeds data back to the primary care and cardiology team. Primary care providers and cardiol-
ogists use a web-based system to communicate and manage care
Comparison: Usual care - based on national guidelines for hypertension management
Outcomes Main outcomes: Changes in mean systolic blood pressure
Other outcomes: Changes in mean diastolic blood pressure; hypertension control rate; medication
adherence
Starting date September 2016 (estimated completion date August 2018)
Contact information Lei Xu (waqyl@126.com)
Notes No published results found, contact authors emailed twice for further information, no reply. Trial
registry NCT02919033
Xu 2017  (Continued)
DM1 or DM2: Type 1 or Type 2 Diabetes Mellitus; EMS: Emergency medical service; GP: General practitioner; HCP: Healthcare professionals
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Comparison 1.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Providers' adherence to recommended practice, guidelines or protocols




Statistical method Effect size
1.1 Providers' adherence to recommended guidelines 1   Other data No numeric data
 
 
Analysis 1.1.   Comparison 1: Mobile technologies used by primary care providers to consult
with a hospital-based specialist compared to usual care: Providers' adherence to recommended
practice, guidelines or protocols, Outcome 1: Providers' adherence to recommended guidelines
 
Providers' adherence to recommended guidelines
Study Population Outcome Results Notes
Van Gelder 2017 General practitioners consult-
ing with nephrologists about
adults with chronic kidney dis-
ease
Complete monitoring of dis-
ease progression
Complete monitoring of meta-
bolic parameters
OR 1.23 (0.89 to 1.70)
OR 0.61 (0.22 to 1.72)
Follow-up not specified
OR: Odds ratio; IG: interven-
tion group; CG: control group
* Multilevel analysis for IG
compared to CG; model with a
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Comparison 2.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Time between presentation and management of the health condition




Statistical method Effect size
2.1 Time between presentation and management 4   Other data No numeric data
 
 
Analysis 2.1.   Comparison 2: Mobile technologies used by primary care providers to consult
with a hospital-based specialist compared to usual care: Time between presentation and
management of the health condition, Outcome 1: Time between presentation and management
 
Time between presentation and management
Study Population Outcome Results Notes
Azogil-López 2019 General practitioner consult-
ing with hospital physicians
about participants (aged ≥ 7
years)
Median time from referral re-
quest to appointment with
hospital physician
Median time from referral
request to resolution of the
process
IG: 17 days (IQR 8 to 32, N = 72)
CG: 51 days, (IQR 35 to 57 days,
N = 101)
Median difference: −27 days
(99% CI −20 to −33 days)*
IG: 105 days (IQR 40 to 169);
CG: 147 days (IQR 74 to 228)
Median difference: −47 days
(95% CI −74 to −17 days)*
IG: Intervention group; CG:
Control group; IQR: Interquar-
tile range
3-month follow-up
* As reported by the authors
Piette 2017 General practitioner consult-
ing with dermatologists about
adults with skin lesions
Median delay between
the initial GP’s consultation
and the dermatologist’s reply
allowing the participant or the
GP to begin treatment
IG: 4 days (N = 53)
CG: 40 days (N = 50)
Adjusted HR 2.55 (P = 0.01)*
3-month follow-up
Reported in days
Data also provided for number
of participants not receiving
an appointment (15 days, 1-, 2-
and 3-month follow-up)
Adjusted hazard ratio (HR) as
provided by the authors (ad-
justing for clustering of GPs
and identities of dermatolo-
gists)
Sutherland 2009 General practitioner consult-
ing with radiologists about
clients aged ≥ 13 years requir-
ing a trans-abdominal or trans-
vaginal ultrasound
Median time to participant fol-
low-up
Median time to final diagnosis
IG: 67.1 hours (IQR: 45.9 to
113.7, N = 53)
CG: 76.7 hours (IQR 65.8 to
144.7, N = 52)
IG: 17.8 hours (IQR: 12.2 to
27.1, N = 53)
CG: 23.9 (IQR 21.4 to 48.1, N =
52)
Duration not provided
Whited 2002 General practitioner consult-
ing with dermatologists about
adults with skin condition
Mean time to intervention IG: 73.8 days (SD 71.6, N = 135)
CG: 114.3 days (SD 72.3, N =
140)
MD: −40.5 days (95% CI −23.41
to −57.89)
Duration not provided




Comparison 3.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Healthcare use





Statistical method Effect size
3.1 Healthcare use 9   Other data No numeric data
3.1.1 Healthcare use 9   Other data No numeric data
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Statistical method Effect size
3.2 Referred for clinic follow-up or clinical exami-
nation, 3 to 12 months follow-up
3   Risk Ratio (M-H, Random,
95% CI)
Totals not selected
3.2.1 Referred to a dermatology clinic 3   Risk Ratio (M-H, Random,
95% CI)
Totals not selected
3.3 Referred for clinic follow-up or clinical exami-
nation, 3 to 12 months follow-up





Analysis 3.1.   Comparison 3: Mobile technologies used by primary care providers to consult with
a hospital-based specialist compared to usual care: Healthcare use, Outcome 1: Healthcare use
 
Healthcare use
Study Population Outcome Results Notes
Healthcare use
Byamba 2015 General practitioner consult-
ing with dermatologists about
adults with skin lesions
Participant referred to ter-




RR: 0.28, 95% CI 0.13 to 0.63
IG: Intervention group; CG:
Control group
RR: risk ratio; CI: confidence
interval
5 months follow-up
Note: there was no evidence of
clustering taken into account
in the analysis, and we were
not able to re-analyse the data.
It is possible there are poten-
tial unit of analysis errors.
Davis 2003 Primary care provider at the
rural primary practice consult-
ing with ophthalmologist at






RR 5.56 (95% CI 2.19 to 14.10)
Follow-up not reported
RR: risk ratio; CI: confidence
interval
Liddy 2019a Primary care provider consult-
ing with specialists for a range
of different conditions
Participants referred for face-
to-face visits to all medical
specialties available through
eConsult service during the
study period
Mean number of participants
seen (SD, range)
IG: 608 (258, 90 to 1134)
CG: 724 (370, 11 to 1692)
RR 0.93, 95% CI 0.85 to 1.03*
12-month follow-up
RR: risk ratio; CI: confidence
interval
* Adjusted for covariates
Mansberger 2015 Primary care providers con-
sulting with experienced in-
vestigators based at an eye in-






RR 1.60 (95% CI 1.31 to 1.95)
12-month follow-up (24, 36
and 48 months also reported;
during these periods telemed-
icine was offered to all partici-
pants)
Piette 2017 General practitioner consult-
ing with dermatologists about
adults with skin lesions
Participant referred for clinic
follow-up
IG: 14/39*; CG: 50/50
RR: 0.36 (95% CI 0.24 to 0.55)
3-month follow-up
* Only includes participants for
whom
dermatologists were able to
elaborate a treatment plan
based on transmitted pho-
tographs; for approx. 1/5 of
participants allocated to IG the
photographs were not usable
Sutherland 2009 General practitioner consult-
ing with radiologists regarding
clients aged ≥ 13 years requir-






RR 3.92 (95% CI 2.11 to 7.31)
Follow-up not specified
RR: risk ratio; CI: confidence
interval
Van Gelder 2017 General practitioners consult-
ing with nephrologists about
adults with chronic kidney dis-
ease




OR 0.61 (95% CI 0.31 to 1.23)*
Follow-up not specified
OR: Odds ratio; CI: confidence
interval
* Multilevel analysis for IG
compared to CG; model with a
random intercept keeping the
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Whited 2002 General practitioners consult-
ing with dermatologists about
adults with skin condition
Participant referred for clinic
follow-up
IG: 110/135; CG: 140/140
RR: 0.82 (95% CI 0.75 to 0.88)
Follow-up not specified
RR: risk ratio; CI: confidence
interval
Whited 2013 General practitioner consult-
ing with dermatologists about





RR 0.71 (95% CI 0.61 to 0.82)
Proportion of participats who
had at least 1 visit to the der-




Analysis 3.2.   Comparison 3: Mobile technologies used by primary care providers
to consult with a hospital-based specialist compared to usual care: Healthcare use,
Outcome 2: Referred for clinic follow-up or clinical examination, 3 to 12 months follow-up
Study or Subgroup























M-H, Random, 95% CI
0.37 [0.24 , 0.55]
0.82 [0.75 , 0.88]
0.71 [0.61 , 0.82]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours mobile-based Favours usual care
 
 
Analysis 3.3.   Comparison 3: Mobile technologies used by primary care providers
to consult with a hospital-based specialist compared to usual care: Healthcare use,



















M-H, Random, 95% CI
5.56 [2.19 , 14.10]
1.60 [1.31 , 1.95]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours mobile-based Favours usual care
 
 
Comparison 4.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Participant's healthcare status and well-being





Statistical method Effect size
4.1 Health-related quality of life 2   Other data No numeric data
4.2 Clinical course 2   Other data No numeric data
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Analysis 4.1.   Comparison 4: Mobile technologies used by primary care providers
to consult with a hospital-based specialist compared to usual care: Participant's
healthcare status and well-being, Outcome 1: Health-related quality of life
 
Health-related quality of life
Study Population Outcome Results Notes
Armstrong 2018 General practitioner consult-
ing with dermatologists about
adults with psoriasis
General health status: Descrip-
tion
General health status: Evalua-
tion
MD 0 (95% CI −0.003 to 0.003)
MD −0.002 (95% CI −2.75 to
2.75)
General health status - De-
scription assessed with Euro-
Qol-5D-5L. Scores converted
into an index number, with
values ranging from −0.109
(worst) to 1 (best).
General health status - Evalua-
tion assessed with EuroQol-Vi-
sual Analogue Scale. Higher
scores represent better per-
ceived health status
Mean difference from baseline
to 12 months follow-up, 296
participants.
MD: mean difference; CI: confi-
dence interval
Whited 2013 General practitioner consult-
ing with dermatologists about
adults with skin condition
Quality of life: Composite
Health-related quality of life
IG: MD −12.0 (SD 24.5, N = 160)
CG: MD −13.2 (SD 21.6, N = 166)
Similar scores between groups
throughout the trial
Quality of life assessed with
Skindex-16, 0 - 100
Higher scores represent worse
quality of life
Health-related quality of life
(HRQoL) assessed with Short-
Form Health Survey 12 (SF-12)
Higher scores represent better
HRQoL
Mean difference from baseline
to 9-month follow-up
IG: intervention group; CG:
control group; MD: mean dif-




Analysis 4.2.   Comparison 4: Mobile technologies used by primary care providers to consult with a hospital-based
specialist compared to usual care: Participant's healthcare status and well-being, Outcome 2: Clinical course
 
Clinical course
Study Population Outcome Results Notes
Pak 2007 Primary care professional con-
sulting with dermatologist
about adults with skin condi-
tion
Clinical course ratings Improved
IG: 173/272, CG: 154/236
No change
IG: 89/272; CG: 76/236
Worse
IG: 10/272; CG: 6/236
Based on dermatologist's as-
sessment, at four-month fol-
low-up
There was little or no differ-
ence between groups
Whited 2013 General practitioner consult-
ing with dermatologists about
adults with skin condition
Clinical course ratings Resolved
IG: 31/125; CG: 35/136
Improved
IG: 59/125; CG: 63/136
Unchanged (not clinically rele-
vant)
IG: 13/125; CG: 15/136
Unchanged (clinically relevant)
IG: 13/125; CG: 17/136
Worse
IG: 9/125; CG: 6/136
Based on dermatologist's as-
sessment, at nine-month fol-
low-up
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Comparison 5.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Acceptability or satisfaction








5.1 Healthcare provider satisfaction with the intervention 3   Other data No numeric data
5.2 Participant satisfaction with care 4   Other data No numeric data
 
 
Analysis 5.1.   Comparison 5: Mobile technologies used by primary care providers
to consult with a hospital-based specialist compared to usual care: Acceptability
or satisfaction, Outcome 1: Healthcare provider satisfaction with the intervention
 
Healthcare provider satisfaction with the intervention
Study Population Outcome Results Notes
Piette 2017 General practitioners consult-
ing with dermatologists about
adults with a skin condition
Satisfaction Global satisfaction
Same proportion of GPs in
both groups were satisfied or
very satisfied (69%)
Time to treatment satisfaction
Similar proportion of GPs in
both groups considered the
time for resolution to be short
or very short (IG: 77%; CG:
54%)
Response rate: 65% (N = 26)
2 questions with a Likert scale
response (1 very satisfied to 4
very unsatisfied)
Results provided narratively
Van Gelder 2017 General practitioners consult-
ing with nephrologists about
adults with chronic kidney dis-
ease
Exprience with the interven-
tion
Content of information sent
was good
Yes: 71%; No: 13%; Did not use:
16%
Ease of use
Good: 39%; Reasonable: 37%;
Insufficient: 8%; Did not use:
16%
Added to knowledge of kidney
disease
Yes: 68%; No: 16%; Did not use:
16%
Pleased with feasibility of te-
lenephrology
Yes: 79%; No: 5%; Did not use:
16%
Intervention group only (gen-
eral practitioners)
Response rate: 66% (N = 36)
Whited 2002 General practitioners consult-
ing with dermatologists about
adults with a skin condition
Satisfaction with the interven-
tion
N = 275 participants
Timely appointments (GPs)
IG: 95% agreed, 5% neutral
CG: 7% agreed, 70% disagreed
Consultant sent back informa-
tion (GPs)
IG: 87% agreed, 13% neutral
CG: 68% agreed, 17% neutral
Educational benefit from the
referral (GPs)
IG: 55% agreed, 45% neutral
CG: 34% agreed, 41% neutral
Satisfied with the consult
process (GPs)
IG: 92% agreed, 3% disagreed
CG: 23% agreed, 35% dis-
agreed
Less confident with TD than FtF
(CD)
75% agree, 12.5% disagree
TD consultation takes longer
(CD)
100% disagree
IG: intervention group; CG:
control group;
TD: teledermatology; FtF: face-
to-face; CD: consulting derma-
tologists
GPs: 4 questions relating to
timeliness, information trans-
fer, education, and overall sat-
isfaction; score agree, neutral,
disagree
Referring GPs (N = 60)
Dermatologists: confidence in
using TD for diagnostic
and management, resource
use, and overall satisfaction;
score agree, neutral, disagree
CD (N = 8)
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TD makes it easier to triage
clients (CD)
100% agree
Satisfied with using TD (CD)
75% agree, 25% neutral
 
 
Analysis 5.2.   Comparison 5: Mobile technologies used by primary care providers to consult with a hospital-based
specialist compared to usual care: Acceptability or satisfaction, Outcome 2: Participant satisfaction with care
 
Participant satisfaction with care
Study Population Outcomes Results Notes
Eminović 2009 General practitioners consult-
ing with dermatologists about
adults with skin condition
General satisfaction
Interpersonal aspects of care
IG: Mean 3.8 (SD 0.59, N = 191)
CG: Mean 3.8 (SD 0.59, N = 159)
MD: 0.0 (95% CI −0.12 to 0.12)
IG: Mean 4.13 (SD 0.62, N = 191)
CG: Mean 4.15 (SD 0.73, N =
159)
MD: 0.2 (95% CI −0.12 to 0.16)
Shortened version of the Pa-
tient Satisfaction Question-
naire (PSQ III)
1 - 5, higher scores indicate
more satisfaction with the care
received
1 month follow-up
IG: Intervention group; CG:
Control group; SD: standard
deviation;
MD: mean difference; CI: confi-
dence interval
Piette 2017 General practitioner consult-
ing with dermatologists re-
garding adults with skin le-
sions
Global satisfaction
Time to treatment satisfaction
Similar proportion of partici-
pants in both groups were sat-
isfied or very satisfied (IG: 85%;
CG: 94%)
Higher proportion of partici-
pants in the IG considered the
time for resolution to be short
or very short, compared to the
CG (46%)*
Response rate: 100% (N = 103)
2 questions with a Likert scale
response (1 very satisfied to 4
very unsatisfied)
Results provided narratively
P = 0.20, as provided by the au-
thors
Whited 2002 General practitioner consult-
ing with dermatologists re-
garding adults with skin condi-
tion
Satisfaction There was little or no differ-
ence between IG (N = 101) and
CG (N = 93)*
Visit-specific satisfaction ques-
tionnaire (VSQ), 1 - 5, higher
scores indicate more satisfac-
tion
1 month follow-up
* As reported by study authors,
no usable data
Whited 2013 General practitioner consult-
ing with dermatologists re-
garding adults with skin condi-
tion
Overall satisfied with the care
received for skin problem
Agree/strongly agree: IG:
86.8%; CG: 92%




global satisfaction with the
care received
9 months follow-up
N = 159 (IG) and 166 (CG)
 
 
Comparison 6.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Costs




Statistical method Effect size
6.1 Costs 6   Other data No numeric data
 
 
Analysis 6.1.   Comparison 6: Mobile technologies used by primary care providers to
consult with a hospital-based specialist compared to usual care: Costs, Outcome 1: Costs
 
Costs
Study Population Outcome Results Notes
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Byamba 2015 General practitioners consult-
ing with dermatologists about
adults with skin lesions
Total mean costs IG: USD 320
CG: USD 3174
Difference: USD 2854*
IG: intervention group; CG:
control group
Costs calculated in USD (2014)
*Data as provided by the au-
thors; no further information
available
5 months follow-up
Note: there was no evidence of
clustering taken into account
in the analysis, and we were
not able to re-analyse the data.
It is possible there are poten-
tial unit of analysis errors.
Eminović 2009 General practitioners consult-
ing with dermatologists about
adults with a skin condition
Total mean costs IG: EUR 387 (95% CI 281 to
502.5, N = 312)
CG: EUR 354 (95% CI 228 to
484, N = 293)
MD: EUR 32.5 (95% CI −29.0 to
74.7)*
Costs calculated in EUR (2003)
1-month follow-up
MD: mean difference; CI: confi-
dence interval
* Data as provided by authors
Pak 2007 Primary care professional con-
sulting with dermatologist
about adults with skin condi-
tion
Total mean costs Total direct cost
IG: USD 103,043 (SD:294, N =
351), CG: 98,365 (283, N = 347)
MD: USD −4678 (95% CI −4720
to −4635)
Lost productivity
IG: USD 16,359 (SD:47, N = 351)
CG: USD 30,768 (SD 89, N =
347)
MD: USD 14,409 (95% CI 14,398
to 14,419)
Total direct costs include con-
sultations,
laboratory analyses and proce-
dures and medications
Costs calculated in USD (2006)
4-month follow-up
Van Gelder 2017 General practitioners consult-
ing with nephrologists about
adults with chronic kidney dis-
ease
Mean cost per participant IG: EUR 453.86 (95% CI 392.98
to 514.74; N = 1277)
CG: EUR 433.74 (95% CI 387.64
to 479.84; N = 1727)
(P = 0.60)
Main related medical costs, in-
cluding number of contacts
between healthcare providers
and participant, as well as be-
tween healthcare providers;
lab costs; prescriptions; re-
ferrals to secondary for renal
care.
Costs calculated in EUR (2017)
Follow-up not specified
Whited 2002 General practitioners consult-
ing with dermatologists about
adults with skin condition
Mean expected cost per partic-
ipant per visit
Using basic technology
IG: USD 40.35; CG: USD 26.50
Using more advanced technol-
ogy
IG: USD 33.10; CG: USD 21.40
Follow-up not specified
Costs calculated in USD (2002)
N = 275 participants
Whited 2013 General practitioners consult-
ing with dermatologists about
adults with skin condition
Mean total costs per partici-
pant
Healthcare system perspective*
IG: USD 308 (SD 298; N = 195)
CG: USD 338 (SD 291; N = 196)
MD: USD 30 (95% CI USD −79 to
20)
Societal perspective**
IG: USD 460 (SD 428; N = 195)
CG: USD 542 (SD 403; N = 196)
MD USD −82 (95% CI USD −12
to −152)




** Travel, loss of productivity,
other dermatology care
USD Follow-up 9 months
Costs calculated in USD (2011)
 
 
Comparison 7.   Mobile technologies used by primary care providers to consult with a hospital-based specialist
compared to usual care: Technical di0iculties





Statistical method Effect size
7.1 Technical difficulties 4   Other data No numeric data
7.1.1 Quality of the data transmitted 4   Other data No numeric data
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Analysis 7.1.   Comparison 7: Mobile technologies used by primary care providers to consult with a
hospital-based specialist compared to usual care: Technical di0iculties, Outcome 1: Technical di0iculties
 
Technical difficulties
Study Population Outcome Results Notes
Quality of the data transmitted
Pak 2007 Primary care providers con-
sulting with dermatologist
about adults referred to the
dermatology service from pri-
mary care clinics
Technical problems 20/528 participants’ images
were lost
10 images in each group
Piette 2017 General practitioner consult-
ing with dermatologists about
adults with skin lesions
Technical quality of the im-
ages received
11/53 participants' images did
not have enough quality as to
allow diagnosis or treatment
or both
Intervention group only
The dermatologist was able
to make a decision about the
need of an in-person appoint-
ment for 8 of the clients, based
on the clinical notes sent along
with the images
Sutherland 2009 General practitioner consult-
ing with radiologists about
clients aged ≥ 13 years requir-
ing a trans-abdominal or trans-
vaginal ultrasound
Technical quality of the im-
ages received
Mean 4.6 (standard deviation
0.5)
Procedural quality
Mean 4.7 (standard deviation
0.6)
As rated by 6 radiologists
based on 53 scans, delivered
by email; 1 - 5, higher scores
represent better quality of the
images and the procedure
Intervention group only
Whited 2002 General practitioner consult-
ing with dermatologists about
adults referred to the derma-
tology service from primary
care clinics
Technical quality of the im-
ages received
Due to the bad quality of the
images transmitted, 1/134
clients allocated to the IG re-





Comparison 8.   Mobile technologies for use in the emergency department compared to usual care: Time between
presentation and management of the health condition




Statistical method Effect size
8.1 Time between presentation and management 1   Other data No numeric data
 
 
Analysis 8.1.   Comparison 8: Mobile technologies for use in the emergency
department compared to usual care: Time between presentation and management
of the health condition, Outcome 1: Time between presentation and management
 
Time between presentation and management
Study Population Outcome Results Notes
Gulacti 2017 Emergency physicians con-
sulting with specialists about
adults attending the emer-
gency department; duration
not provided
Median consult time* IG: 158 minutes (IQR:133 to
177.25, 95% CI:150 to169, N =
173)
CG: 170 minutes (IQR:165 to
188.5, 95% CI: 170 to 171, N =
172)
Median difference: −12 min-
utes (95% CI: −19 to −7), P <
0.0001**
* Time when consultation was
requested
minus time when a bed was re-
quested (for admission to hos-
pital) or discharge time
IG: intervention group; CG:
control group; CI: confidence
interval
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Comparison 9.   Mobile technologies for use in the emergency department compared to usual care: Healthcare use




Statistical method Effect size
9.1 Healthcare use 1   Other data No numeric data
 
 
Analysis 9.1.   Comparison 9: Mobile technologies for use in the emergency
department compared to usual care: Healthcare use, Outcome 1: Healthcare use
 
Healthcare use
Study Population Outcome Results Notes
Gulacti 2017 Emergency physicians con-
sulting with specialists about
adults attending the emer-
gency department
Median emergency depart-
ment length of stay
IG: 240 minutes (IQR: 230 to
270, 95% CI: 240 to 255.2, N =
173)
CG: 277 minutes (IQR: 270 to
287.8, 95% CI:277 to 279, N =
172)
Median difference −30 min-
utes, 95% CI −37 to −25*
IG: intervention group; CG:
control group; IQR: interquar-
tile range; CI: confidence inter-
val
Follow-up not specified




Comparison 10.   Mobile technologies for use in the emergency department compared to usual care: Technical
di0iculties





Statistical method Effect size
10.1 Technical difficulties 1   Other data No numeric data
10.1.1 Quality of the data transmitted 1   Other data No numeric data
 
 
Analysis 10.1.   Comparison 10: Mobile technologies for use in the emergency department
compared to usual care: Technical di0iculties, Outcome 1: Technical di0iculties
 
Technical difficulties
Study Population Outcome Results Notes
Quality of the data transmitted
Gulacti 2017 Emergency physicians con-
sulting with specialists about
adults attending the emer-
gency department
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Comparison 11.   Mobile technologies used by community health workers or home-care workers compared to usual
care: Healthcare use




Statistical method Effect size
11.1 Healthcare use 2   Other data No numeric data
 
 
Analysis 11.1.   Comparison 11: Mobile technologies used by community health workers or
home-care workers compared to usual care: Healthcare use, Outcome 1: Healthcare use
 
Healthcare use
Study Population Outcome Results Notes
Iversen 2018 Community nurses consulting
with diabetes specialist nurses
and podiatrists about adults





IG: Mean 2.8 (SD 1.9, N = 94),
CG: Mean 2.5 (SD 3.0, N = 88)
MD −0.48 (95% CI −1.46 to 0.49)
IG: M 6.7 (SD 3.4, N = 94), CG: M
5.9 (SD 4.6, N = 88)
MD 0.92 (95% CI −0.70 to 2.53)
12-month follow-up
SD: standard deviation; MD:
mean difference; CI: confi-
dence interval
Orlandoni 2016 Home-visiting nursing staF
consulting with a hospital
physician about older adults




Incidence rate ratio 95% CI:
0.65 to 1.30, P = 0.62
Incidence rate ratio 95% CI:
0.54 to 1.19, P = 0.26*
12-month follow-up




Comparison 12.   Mobile technologies used by community health workers or home-care workers compared to usual
care: Participant's healthcare status and well-being




Statistical method Effect size
12.1 Participant healthcare status and well-being 3   Other data No numeric data
 
 
Analysis 12.1.   Comparison 12: Mobile technologies used by community health
workers or home-care workers compared to usual care: Participant's healthcare
status and well-being, Outcome 1: Participant healthcare status and well-being
 
Participant healthcare status and well-being
Study Population Outcome Results Notes
Chang 2011 Community-based peer health
workers consulting with clinic
staF about adults who were
receiving or started receiving
antiretroviral therapy
Mortality IG: 37/446; CG: 53/524
RR 0.82, 95% CI 0.55 to 1.22
Average follow-up: 103 weeks
Iversen 2018 Community nurses consulting
with diabetes specialist nurses
and podiatrists about adults
aged ≥ 20 years with new dia-
betes-related foot ulcers
Mortality IG: 5/99; CG 5/88
RR 0.94, 95% CI 0.28 to 3.12
12 months follow-up
Taylor-Gjevre 2018 Rural-based physical ther-
apists consulting with ur-
ban-based rheumatologists
about adults with a clinical di-
agnosis of rheumatoid arthritis
Disease activity
Health-related quality of life
DAS28-CRPa
MD 0.9 (95% CI −1.2 to 3.1, P =
0.33)
mHAQb
MD 0.2 (95% CI −0.1 to 0.5, P =
0.14)
aDisease activity score for
rheumatoid arthritis, higher
scores represent greater dis-
ease activity
b Modified health assessment
questionnaire, 0 - 3, higher
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RADAIc
MD 0.9 (95% CI −0.5 to 2.4, P =
0.19)
EQ5Dd
MD −0.1 (95% CI −0.4 to 0.1, P
= 0.29)*
scores represent greater im-
pairment
cRheumatoid arthritis disease
activity index, 0 - 10, higher
scores represent greater dis-
ease activity
dEuroQol 5 dimensions ques-
tionnaire (EQ5D), 0 - 1, higher
scores represent better health-
related quality of life
Mean difference (MD) between
groups, (Control (N = 31), Inter-
vention (N = 54)), from base-
line to 9-month follow-up




Comparison 13.   Mobile technologies used by community health workers or home-care workers compared to usual
care: Acceptability or satisfaction




Statistical method Effect size
13.1 Participant satisfaction with care 2   Other data No numeric data
 
 
Analysis 13.1.   Comparison 13: Mobile technologies used by community health workers or home-care
workers compared to usual care: Acceptability or satisfaction, Outcome 1: Participant satisfaction with care
 
Participant satisfaction with care
Study Population Outcome Results Notes
Iversen 2018 Community nurses consulting
with diabetes specialist nurses
and podiatrists about adults
aged ≥ 20 years with new dia-
betes-related foot ulcers
Experience with healthcare IG: M 4.4 (SD 0.5, N = 67)
CG: M 4.4 (SD 0.5, N = 57)
MD: 0.0 (95% CI −0.18 to 0.18)
Generic Short Patient Experi-
ences Questionnaire (GS-PEQ),
1 - 5, higher scores indicate
more satisfaction
12-month follow-up
Taylor-Gjevre 2018 Rural-based physical ther-
apists consulting with ur-
ban-based rheumatologists
about adults with a clinical di-
agnosis of rheumatoid arthritis
Participant satisfaction There was little or no differ-
ence between IG (N = 31) and
CG (N = 23)*
Visit specific satisfaction ques-
tionnaire (VSQ9), 1 - 5, higher
scores indicate more satisfac-
tion
9-month follow-up




Comparison 14.   Mobile technologies used by community health workers or home-care workers compared to usual
care: Costs




Statistical method Effect size
14.1 Costs 1   Other data No numeric data
 
 
Analysis 14.1.   Comparison 14: Mobile technologies used by community health
workers or home-care workers compared to usual care: Costs, Outcome 1: Costs
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Costs
Study Population Outcome Results Notes
Chang 2011 Community-based peer health
workers consulting with clinic
staF about adults who were
receiving or started receiving
antiretroviral therapy
Yearly total cost of running the
mHealth intervention
Cost per participant




Intervention arm only, costs
calculated in Ugandan
shillings and converted to USD
(2011).
Does not include cost of a pre-
viously set-up intervention
to train peer health workers,
to which the mHealth was an
add-on
Average follow-up: 103 weeks
 
 
Comparison 15.   Mobile technologies used by community health workers or home-care workers compared to usual
care: Technical di0iculties








15.1 Technical difficulties 2   Other data No numeric data
15.1.1 Quality of the data transmitted 1   Other data No numeric data
15.1.2 Technical difficulties reported by the healthcare pro-
fessionals
1   Other data No numeric data
 
 
Analysis 15.1.   Comparison 15: Mobile technologies used by community health workers or home-
care workers compared to usual care: Technical di0iculties, Outcome 1: Technical di0iculties
 
Technical difficulties
Study Population Outcomes Results Notes
Quality of the data transmitted
Taylor-Gjevre 2018 Community nurses consulting
with diabetes specialist nurses
and podiatrists about adults
aged ≥ 20 years with new dia-
betes-related foot ulcers
Technical problems For 10 video-conferencing vis-
its images were not transmit-
ted and only an audio-link was
available
Unclear how many visits were
conducted in total
Intervention group only
Technical difficulties reported by the healthcare professionals
Chang 2011 Community-based peer health
workers consulting with clinic
staF about adults who were
receiving or started receiving
antiretroviral therapy
Problems with the equipment Healthcare professionals were
not always able to charge the
mobile phone
Some mobile phones were
stolen
Qualitative outcomes based





A D D I T I O N A L   T A B L E S
 
Study Incentives Specific training
Armstrong 2018 Participants were paid
for participating in the
study, through giN cards
Participants and their carers were taught how to take standardised images of
skin lesions, as well as how to communicate with the dermatologist using a se-
cure web-based system. PCPs also had access to the training materials. (Protocol,
p.19, 2nd paragraph)
Table 1.   Intervention components 
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(main paper, p.3, end
1st paragraph)
Byamba 2015 - GPs attended a 2-day training session to learn how to take images and use the
medical record system and software on mobile phones (p.1, top 2nd column)
Chang 2011 PHWs were given a bi-
cycle, t-shirts, basic
supplies, and an ini-
tial monthly allowance
(parent trial)
PHWs allocated to the intervention group were given a mobile phone, and at-
tended a 1-day residential training and a brief field-based practical training on
the intervention (main paper, p.3, 2nd paragraph)
Eminović 2009 - GPs allocated to the intervention group received detailed instructions on how to
take digital images and use the web-based form (main paper, p.559, bottom 1st
column)
Iversen 2018 - All staF received training in the use of the web-based system, as well as in-person
access to hospital clinics to improve their practical skills (main paper, pp.97-8)
Liddy 2019a Specialists received fi-
nancial incentives for








ed paper, p.524, bottom
1st column)
Technicians performing imaging attended a 3-day training session to learn how
to take images and ongoing feedback as needed (main paper, p.943, bottom 1st
column)
Piette 2017 - GPs received training and a workbook on how to take photographs (p.2, top 2nd
column)
Sutherland 2009 - The on-site investigator received sonographic training over a 2-month period, as
well as practice guidelines for trans-abdominal ultrasound scanning (P. 192, mid
1st column and top 2nd column)
Taylor-Gjevre 2018 - Physical therapists and rheumatologists received an orientation and education
session about rheumatoid arthritis and the study protocol and methods (main
paper, p.2, top 2nd column)
Table 1.   Intervention components  (Continued)
GP: general practitioner; PCP: primary care provider; PHW: peer health workers
 
 





General practitioner consulting with der-
matologists about adults with psoriasis
Participants without access to the Internet and





GP consulting with hospital physicians
about participants (aged ≥ 7 years)
Participants deemed as complex were not eligible




Table 2.   Equity considerations 
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Byamba 2015 GP consulting with dermatologists about
adults with skin lesions
Intervention was set in rural health clinics in Mon-
golia
-
Chang 2011 Community-based peer health workers
consulting with clinic staF about adults
who were receiving or started receiving
antiretroviral therapy
Specifically targeted HIV-positive participants in
rural Uganda. However, many participants had
limited access to mobile phones*, which might
have limited the benefits of the intervention.
For the healthcare providers, the costs of the in-
tervention were also a factor, as although they
were given a monthly stipend it was not always
enough
Charging the mobile phone was often challeng-








Davis 2003 PCPs at the rural primary practice con-
sulting with ophthalmologist in the uni-
versity setting about adults with Type 2
diabetes
Specifically targeted rural-based ethnic minori-
ties, 35% of whom did not have health insurance
-
Gulacti 2017 Emergency physicians consulting with
specialists about adults attending the
emergency department
Only consultants who owned a smartphone and





PCPs consulting with experienced inves-
tigators based at an eye institute about
adults with Type 2 diabetes
Primary clinics that served a large number of eth-
nic minorities, including a high percentage of par-
ticipants with transient housing
-
Piette 2017 General practitioners consulting with der-
matologists about adults with skin le-
sions
Participants who were not able to attend in-per-
son appointments at the dermatologist office
were excluded, i.e. participants unable to travel or




GP consulting with radiologists about
participants aged ≥ 13 years requiring a
trans-abdominal or trans-vaginal ultra-
sound
Sample was composed mainly of low-skilled
workers relying on government-supported prima-




Community nurses consulting with dia-
betes specialist nurses and podiatrists
about adults aged ≥ 20 years with new di-
abetes-related foot ulcers
Specifically targeted rural-based adults -
Whited 2013 GP consulting with dermatologists about
adults with skin condition
Participants who could not speak or read English









Table 2.   Equity considerations  (Continued)
GP: General practitioner; PCP: primary care provider; PHW: Peer health workers
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A P P E N D I C E S
Appendix 1. Search strategies and results
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) <1946 to Present> -
Searched 25 September 2018
 
1 exp Health Personnel/
2 (((health or medical or healthcare) adj (personnel or worker* or auxiliar* or staF or professional*))
or doctor* or physician* or GP or general practitioner? or family doctor or nurse* or midwi* or clin-
ical officer* or pharmacist* or dentist* or ((birth or childbirth or labor or labour) adj (attendant? or
assistant?))).ti,ab,kw.
3 ((lay or voluntary or volunteer? or untrained or unlicensed or nonprofessional? or non profession-
al?) adj5 (worker? or visitor? or attendant? or aide or aides or support$ or person$ or helper? or car-
er? or caregiver? or care giver? or consultant? or assistant? or staF)).ti,ab,kw.
4 (paraprofessional? or paramedic or paramedics or paramedical worker? or paramedical per-
sonnel or allied health personnel or allied health worker? or support worker? or home health
aide?).ti,ab,kw.
5 ((community or village? or lay) adj3 (health worker? or health care worker? or healthcare work-
er?)).ti,ab,kw.
6 (doula? or douladural? or barefoot doctor?).ti,ab,kw.





12 ((cell* or mobile*) adj1 (phone* or telephone* or technolog* or device*)).ti,ab,kw.
13 (handheld or hand-held).ti,ab,kw.
14 (smartphone* or smart-phone* or cellphone* or mobiles).ti,ab,kw.
15 ((personal adj1 digital) or (PDA adj3 (device* or assistant*)) or MP3 player* or MP4 player*).ti,ab,kw.
16 (samsung or nokia).ti,ab,kw.
17 (windows adj3 (mobile* or phone*)).ti,ab,kw.
18 android.ti,ab,kw.
19 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*).ti,ab,kw.
20 (tablet* adj3 (device* or computer*)).ti,ab,kw.
21 Telemedicine/
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22 Videoconferencing/ or Webcasts as topic/
23 Text Messaging/
24 Telenursing/
25 (mhealth or m-health or "mobile health" or ehealth or e-health or "electronic health").ti,ab,kw.
26 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or
tele-nursing or telepsychiatry or tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or
tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-coach*).ti,ab,kw.
27 (videoconferenc* or video-conferenc* or webcast* or web-cast*).ti,ab,kw.
28 (((text* or short or voice or multimedia or multi-media or electronic or instant) adj1 messag*) or in-
stant messenger).ti,ab,kw.
29 (texting or texted or texter* or ((sms or mms) adj (service* or messag*)) or interactive voice re-
sponse* or IVR or voice call* or callback* or voice over internet or VOIP).ti,ab,kw.





34 (social adj (media or network*)).ti,ab,kw.
35 Reminder Systems/
36 (remind* adj3 (text* or system* or messag*)).ti,ab,kw.
37 Electronic Mail/
38 (electronic mail* or email* or e-mail or webmail).ti,ab,kw.
39 Medical informatics/ or Medical informatics applications/
40 Nursing informatics/ or Public health informatics/
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47 Computer-Assisted Instruction/
48 ((interactive or computer-assisted) adj1 (tutor* or technolog* or learn* or instruct* or software or
communication)).ti,ab,kw.
49 or/8-48
50 randomized controlled trial.pt.








59 exp animals/ not humans.sh
60 58 not 59
61 7 and 49 and 60
62 limit 61 to yr="2000 -Current"
  (Continued)
 
Embase (Ovid) - Searched 25 September 2018
 
1 mobile phone/ or smartphone/
2 mp3 player/
3 ((cell* or mobile*) adj1 (phone* or telephone* or technolog* or device*)).ti,ab,kw.
4 (handheld or hand-held).ti,ab,kw.
5 (smartphone* or smart-phone* or cellphone* or mobiles).ti,ab,kw.
6 ((personal adj1 digital) or (PDA adj3 (device* or assistant*)) or MP3 player* or MP4 player*).ti,ab,kw.
7 (samsung or nokia).ti,ab,kw.
8 (windows adj3 (mobile* or phone*)).ti,ab,kw.
9 android.ti,ab,kw.
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10 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*).ti,ab,kw.
11 (tablet* adj3 (device* or computer*)).ti,ab,kw.
12 telemedicine/ or telecardiology/ or teleconsultation/ or teledermatology/ or telediagnosis/ or tele-
monitoring/ or telepathology/ or telepsychiatry/ or teleradiotherapy/ or telesurgery/ or telethera-
py/
13 videoconferencing/ or webcast/
14 text messaging/
15 telenursing/
16 (mhealth or m-health or "mobile health" or ehealth or e-health or "electronic health").ti,ab,kw.
17 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or
tele-nursing or telepsychiatry or tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or
tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-coach*).ti,ab,kw.
18 (videoconferenc* or video-conferenc* or webcast* or web-cast*).ti,ab,kw.
19 (((text* or short or voice or multimedia or multi-media or electronic or instant) adj1 messag*) or in-
stant messenger).ti,ab,kw.
20 (texting or texted or texter* or ((sms or mms) adj (service* or messag*)) or interactive voice re-
sponse* or IVR or voice call* or callback* or voice over internet or VOIP).ti,ab,kw.





25 (social adj (media or network*)).ti,ab,kw.
26 reminder system/
27 (remind* adj3 (text* or system* or messag*)).ti,ab,kw.
28 e-mail/
29 (electronic mail* or email* or e-mail or webmail).ti,ab,kw.
30 medical informatics/
31 nursing informatics/
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35 blogging/
36 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-
log*).ti,ab,kw.
37 teaching/
38 ((interactive or computer-assisted) adj1 (tutor* or technolog* or learn* or instruct* or software or
communication)).ti,ab,kw.
39 or/1-38
40 exp health care personnel/
41 (((health or medical or healthcare) adj (personnel or worker* or auxiliar* or staF or professional*))
or doctor* or physician* or GP or general practitioner? or family doctor or nurse* or midwi* or clin-
ical officer* or pharmacist* or dentist* or ((birth or childbirth or labor or labour) adj (attendant? or
assistant?))).ti,ab,kw.
42 ((lay or voluntary or volunteer? or untrained or unlicensed or nonprofessional? or non profession-
al?) adj5 (worker? or visitor? or attendant? or aide or aides or support$ or person$ or helper? or car-
er? or caregiver? or care giver? or consultant? or assistant? or staF)).ti,ab,kw.
43 (paraprofessional? or paramedic or paramedics or paramedical worker? or paramedical per-
sonnel or allied health personnel or allied health worker? or support worker? or home health
aide?).ti,ab,kw.
44 ((community or village? or lay) adj3 (health worker? or health care worker? or healthcare work-
er?)).ti,ab,kw.
45 (doula? or douladural? or barefoot doctor?).ti,ab,kw.
46 or/40-45
47 39 and 46
48 crossover procedure/
49 double blind procedure/




54 (crossover$ or cross over$ or cross-over$).tw.
55 placebo$.tw.
56 (doubl$ adj blind$).tw.
57 (singl$ adj blind$).tw.
58 assign$.tw.
  (Continued)
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62 47 and 61
63 limit 62 to yr="2000 -Current"
64 limit 63 to embase
  (Continued)
 
CENTRAL Register of Trials (Cochrane Library) – Searched 25 September 2018
 
#1 MeSH descriptor: [Health Personnel] explode all trees
#2 (((health or medical or healthcare) near (personnel or worker* or auxiliar* or staF or professional*))
or doctor* or physician* or GP or general practitioner? or family doctor or nurse* or midwi* or clini-
cal officer* or pharmacist* or dentist* or ((birth or childbirth or labor or labour) near (attendant? or
assistant?))):ti,ab,kw
#3 ((lay or voluntary or volunteer? or untrained or unlicensed or nonprofessional? or non profession-
al?) near/5 (worker? or visitor? or attendant? or aide or aides or support* or person* or helper? or
carer? or caregiver? or care giver? or consultant? or assistant? or staF)):ti,ab,kw
#4 (paraprofessional? or paramedic or paramedics or paramedical worker? or paramedical per-
sonnel or allied health personnel or allied health worker? or support worker? or home health
aide?):ti,ab,kw
#5 ((community or village? or lay) near/3 (health worker? or health care worker? or healthcare work-
er?)):ti,ab,kw
#6 (doula? or douladural? or barefoot doctor?):ti,ab,kw
#7 {or #1-#6}
#8 MeSH descriptor: [Cell Phones] this term only
#9 MeSH descriptor: [Smartphone] this term only
#10 MeSH descriptor: [MP3-Player] this term only
#11 MeSH descriptor: [Computers, Handheld] this term only
#12 ((cell* or mobile*) near/1 (phone* or telephone* or technolog* or device*)):ti,ab,kw
#13 (handheld or hand-held):ti,ab,kw
#14 (smartphone* or smart-phone* or cellphone* or mobiles):ti,ab,kw
#15 ((personal near/1 digital) or (PDA near/3 (device* or assistant*)) or MP3 player* or MP4 play-
er*):ti,ab,kw
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#16 (samsung or nokia):ti,ab,kw
#17 (windows near/3 (mobile* or phone*)):ti,ab,kw
#18 android:ti,ab,kw
#19 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*):ti,ab,kw
#20 (tablet* near/3 (device* or computer*)):ti,ab,kw
#21 MeSH descriptor: [Telemedicine] this term only
#22 MeSH descriptor: [Videoconferencing] this term only
#23 MeSH descriptor: [Webcasts as Topic] this term only
#24 MeSH descriptor: [Text Messaging] this term only
#25 MeSH descriptor: [Telenursing] this term only
#26 (mhealth or m-health or "mobile health" or ehealth or e-health or "electronic health"):ti,ab,kw
#27 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or
tele-nursing or telepsychiatry or tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or
tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-coach*):ti,ab,kw
#28 (videoconferenc* or video-conferenc* or webcast* or web-cast*):ti,ab,kw
#29 (((text* or short or voice or multimedia or multi-media or electronic or instant) near/1 messag*) or
instant messenger) .ti,ab,kw
#30 (texting or texted or texter* or ((sms or mms) near (service* or messag*)) or interactive voice re-
sponse* or IVR or voice call* or callback* or voice over internet or VOIP):ti,ab,kw
#31 (Facebook or Twitter or Whatsapp* or Skyp* or YouTube or "You Tube" or Google Hang-
out*):ti,ab,kw
#32 MeSH descriptor: [Mobile Applications] this term only
#33 "mobile app*":ti,ab,kw
#34 MeSH descriptor: [Social Media] this term only
#35 (social near (media or network*)):ti,ab,kw
#36 MeSH descriptor: [Reminder Systems] this term only
#37 (remind* near/3 (text* or system* or messag*)):ti,ab,kw
#38 MeSH descriptor: [Electronic Mail] this term only
#39 (electronic mail* or email* or e-mail or webmail):ti,ab,kw
#40 MeSH descriptor: [Medical Informatics] this term only
#41 MeSH descriptor: [Medical Informatics Applications] this term only
  (Continued)
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#42 MeSH descriptor: [Nursing Informatics] this term only
#43 MeSH descriptor: [Public Health Informatics] this term only
#44 ((medical or clinical or health or healthcare or nurs*) near/3 informatics):ti,ab,kw
#45 MeSH descriptor: [Multimedia] this term only
#46 MeSH descriptor: [Hypermedia] this term only
#47 MeSH descriptor: [Blogging] this term only
#48 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-
log*):ti,ab,kw
#49 MeSH descriptor: [Interactive Tutorial] this term only
#50 MeSH descriptor: [Computer-Assisted Instruction] this term only
#51 ((interactive or computer-assisted) near/1 (tutor* or technolog* or learn* or instruct* or software or
communication)):ti,ab,kw
#52 {or #8-#51}
#53 #7 and #52 Publication Year from 2000 to 2018 in Trials
  (Continued)
 
Popline – Searched 25 September 2018
Keyword:(TEXT MESSAGING OR MOBILE DEVICES OR INFORMATION COMMUNICATION TECHNOLOGY OR CELLULAR PHONE) OR All Fields:
((cell OR cellular OR mobile) AND (phone OR phones OR telephone OR telephones OR technology OR technologies OR device OR devices))
OR smartphone OR smartphones OR smart-phone OR smart-phones OR cellphone OR cellphones OR mobiles OR mhealth OR m-health
OR "mobile health" OR ehealth OR e-health OR "electronic health" OR telemedicine OR tele-medicine OR telehealth OR tele-health OR
telecare OR tele-care OR telenursing OR tele-nursing OR telepsychiatry OR tele-psychiatry OR telemonitor OR telemonitoring OR tele-
monitor OR tele-monitoring OR teleconsult OR teleconsulting OR tele-consult OR tele-consulting OR telecounsel OR telecounseling OR
tele-counsel OR tele-counseling OR telecoach OR telecoaching OR tele-coach OR tele-coaching OR videoconference OR videoconferences
OR videoconferencing OR video-conference OR video-conferences OR video-conferencing OR webcast OR webcasts OR webcasting OR
web-cast OR web-casts OR web-casting OR ((text OR texts OR texting OR short OR voice OR multimedia OR multi-media OR electronic
OR instant) AND (message OR messages OR messaging)) OR "instant messenger" OR texting OR texted OR texter OR texters OR ((sms OR
mms) AND (service OR services OR message OR messages OR messaging)) OR "interactive voice response" OR "interactive voice responses"
OR ivr OR "voice call" OR "voice calls" OR callback OR "voice over internet" OR voip OR "mobile app" OR "mobile apps" OR "mobile
application" OR "mobile applications" OR "social media" OR ((medical OR clinical OR health OR healthcare OR nurse OR nurses OR nursing)
AND informatics)
AND
Keyword: (QUANTITATIVE RESEARCH OR RESEARCH METHODOLOGY OR CLINICAL TRIALS OR CONTROL GROUPS) OR All Fields: (randomised
OR randomized OR "randomly allocated" OR "random allocation" OR "controlled trial" OR "control group" OR "control groups" OR trial)
(2000-2018)
WHO Global Health Library (Regional Indexes only) – 25 September 2018
(mh:(("cell phones" OR smartphone OR mp3-player OR "Computers, Handheld" OR telemedicine OR Videoconferencing OR "Text
Messaging" OR Telenursing OR "Mobile Applications" OR "Reminder Systems" OR "Electronic Mail" OR "Medical Informatics" OR "Nursing
Informatics" OR "Public Health Informatics" OR Multimedia OR Hypermedia OR Blogging OR Telemedicine))) OR (tw:(("cell phone" OR
"cell phones" OR "cellular phone" OR "cellular phones" OR "mobile phone" OR "mobile phones" OR "mobile devices" OR "mobile
devices" OR smartphone OR smartphones OR smart-phone OR smart-phones OR cellphone OR cellphones))) AND (mh:(("Controlled Clinical
Trials, Randomized" OR "Controlled Clinical Trials as Topic" OR "Controlled Clinical Trial" OR "Clinical Trial"))) OR (tw:((randomised OR
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randomized OR "randomly allocated" OR "random allocation" OR "controlled trial" OR "control group" OR "control groups" OR trial))) –
598 hits (2000-2018)
ClinicalTrials.gov – 25 September 2018
Field search: Other Terms: (telemedicine OR telehealth OR telecare OR telenursing OR telepsychiatry OR mhealth OR ehealth) AND ("mobile
phone" OR "mobile phones" OR "mobile devices" OR mobiles OR smartphone OR smartphones) | Studies received on or aNer 01/01/2000
| Studies updated on or before 25/09/2018
WHO ICTRP – 25 September 2018
Search 1:
Title: telemedicine OR telehealth OR telecare OR telenursing OR telepsychiatry OR mhealth OR ehealth
AND
Intervention: mobile device OR mobiles OR smartphone OR phone OR cellphone
Search 2:
Title: mobile device OR mobiles OR smartphone OR phone OR cellphone
AND
Intervention: telemedicine OR telehealth OR telecare OR telenursing OR telepsychiatry OR mhealth OR ehealth
H I S T O R Y
Protocol first published: Issue 1, 2018
Review first published: Issue 8, 2020
C O N T R I B U T I O N S   O F   A U T H O R S
Conceiving and designing the review: MF, DGB, CG, SL, GM, SS, TT
Co-ordinating the review: DGB
Searching, selecting studies and completing the data extraction and grading: ARM, BB, DGB, GV, IRC, MF, NH, TT
Writing the review: DGB, SS
Providing general advice and feedback: ARM, BB, CG, DGB, GM, GV, IRC, MF, NH, SL, SS, TT
Securing funding for the review: GM, TT
D E C L A R A T I O N S   O F   I N T E R E S T
ARM: Consultancy from Infarmed - national authority of medicines and health products. Health Technology Assessment Commission.
Payment for development of education presentations from Portuguese Institute of Oncology - Lisbon.
BB: none known.
CG: none known.
DGB: "I was commissioned by the WHO to conduct this review."
GM: owns stock in Apple Computer.
GV: "Since October 2017 I have been employed by Cochrane Response, an evidence services unit operated by the Cochrane Collaboration
and contracted by the WHO to produce this review."
IRC: none known.
MF: none known.
NH: "Since June 2016 I have been employed by Cochrane Response, an evidence services unit operated by the Cochrane Collaboration
and contracted by the WHO to produce this review".
SL: "I am the Joint Co-ordinating Editor for the Cochrane EFective Practice and Organisation of Care Review Group. I am also a member of
the WHO Executive Guideline Steering Group on maternal and perinatal health recommendations".
SS: "I am the Joint Co-ordinating Editor for the Cochrane EFective Practice and Organisation of Care Review Group."
TT: none known.
S O U R C E S   O F   S U P P O R T
Internal sources
• National Institute of Medical Research, UK
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External sources
• UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction
(HRP), a cosponsored program executed by the World Health Organization (WHO), Switzerland
Provided funding for the review.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We stated in the protocol that there would be one 'Summary of findings' table per comparison, and that we would group the trials by
health condition. We did not do this due to the low number of included trials and the large number of diFerent health conditions. Following
discussion among the authors we agreed that stratifying the included studies by setting (community, primary, secondary care) would
provide relatively homogenous groups of studies and that reporting findings by setting would improve the usability of the evidence.
We changed the title from "Mobile-based technologies to support healthcare provider to healthcare provider communication and
management of care" to "Mobile technologies to support healthcare provider to healthcare provider communication and management
of care".
For the outcome 'Healthcare provider and participant acceptability of and satisfaction with the intervention', the protocol stated that both
objective and subjective measures would be included, the former being the number lost to follow-up not explained by other reasons. We
did not measure acceptability or satisfaction using loss to follow-up data, due to insuFicient information.
We split the outcome 'Resource use' into two outcomes ('Healthcare use' and 'Cost').
For the 'Summary of findings' tables, we included participant acceptability and satisfaction alongside healthcare provider acceptability
and satisfaction. The former was already a prespecified outcome in the protocol, but not for the 'Summary of findings' table.
One of the authors leN the team (Nicola Maayan); we added new authors (Ana Rita Maria, Ignacio Ricci-Cabello, Gemma Villanueva).
N O T E S
This review is based on standard text and guidance provided by Cochrane EFective Practice and Organisation of Care (EPOC).
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